{"title": "PDF", "author": "PDF", "url": "www.irsjd.org/media/upload/domain_3/pdf/irsjd-2021-memoria_1658309472.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "cleaned_text": "Recerca Sant Joan de D\u00e9u, Parc Sanitari Sant Joan de D\u00e9u & Institut de Neuroci\u00e8ncies \u00b7 Universitat de BarcelonaSanta Rosa, 39-57 08950 Esplugues de Llobregat \u00b7 Barcelona T. 936 00 97 51 info@irsjd.org www.irsjd.org The cover has been designed by Andrea Casanueva and Giselle Esparza of the Escola d'Art Pau Gargallo within the Talent Creatiu i Empresa program3 INSTITUT DE RECERCA Index Gov ernance structures number s 2015-2021 8 Institutional awar ds 9 2 STAFF 10 Resear ch staff 11 3 PROJEC TS AND CLINICAL TRIALS 1 2 New projects 13 Active pr ojects 13 New clinic al trials and observational studies 14 Active clinic al trials and observational studies 14 4 SCIENTIFIC PRODUCTION AND RESULTS 15 Scientific public ations 16 Highest impact f actor journals 17 Pat ents, utility models and spin-offs 28 Doctor al Theses 30 5 CORE FACILITIES 33 6 TRAINING, COMMUNICATION AND PARTICIPATION 3 5 Seminars 36 T raining programme 37 Communication and public engagement 38 Ne ws 39 7 SCIENTIFIC ACTIVITY 41 7.1. Medicine and pediatric science ar ea 42 Neur erception Acquisition (APAL) 47 Research in child and escent 48 7.1.2. and regulation of adipose tissue and its 52 Neonatol ogy Pharmacol ogical inflammation and metabolic pediatrics ectious diseases and 55 Gut microbiot a 56 Environment and c omplications in pregnancy 57 Car diovascular diseases in development 58 Immune and r espiratory dysfunction in the critical child 59 ergic Precision r Metabolic and mit ochondrial medicine 68 Neur ogenetics and molecular medicine 69 Human mol ecular genetics I 70 Human molecular genetics II 71 Genomics for the diagnosis of r and adolescent welfare 74 Hospital dentis try and periodontal medicine 74 P aediatric ophthalmology 75 Research in nur sing 75 7.2. Mental health ar ea 77 7.2.1. Mental health and society 77 Epidemiology of ment al disorders and aging 78 Health technol ogy assessment in primary care and mental health (PRISMA) 78 Psy chological research group on fibromyalgia and chronic pain (AGORA group) 79 7.2.2. Scientific bases mental disorders and 84 signals 85 Medical t echnologies: computer serious games and gamification 85 Medical t echnologies: biomaterials and tissue engineering 86 Medic al technologies: rehabilitation 86 Medical echnologies: instrumentation and eHealth 87 Medical t echnologies: robotics and 87 Medical t echnologies: biomechanics 88 P atients engagement in research 89 in health technologies 901 FOREWORD Governance numbers 2021 Global numbers 2015-2021 INSTITUT DE RECERCA FOREWORD Governance and structures Dr. Manuel del Castillo Rey General Manager, SJD Barcelona Children's Hospital Dr. Joan Gu\u00e0rdia Olmos Universitat de Barcelona Dr. Jordi Garcia Fernandez Vice-Rector for Research, Universitat de Barcelona Dr. Jordi Berenguer Sau Vice-rector for Knowledge Transfer and Innovation, Universitat Polit\u00e8cnica de Catalunya Dr. Climent Molins Borrell Vocal, Vicerector de Transfer\u00e8ncia, Innovaci\u00f3 i Emprenedoria de la Universitat Polit\u00e8cnica de Catalunya. Mr. Enric Mangas i Monge Director, Parc Sanitari Sant Joan de D\u00e9u Dr. Jaume P\u00e9rez Payarols Director of Innovation and Research, SJD Barcelona Children's Hospital Dr. Josep Maria Haro Abad Director of Research, Innovation and Teaching, Parc Sanitari Sant Joan de D\u00e9u Dr. Francesc Palau Mart\u00ednez Director, Institut de Recerca Sant Joan de D\u00e9u Mr. Emili Bargall\u00f3 Angerri Director, Fundaci\u00f3 de Recerca Sant Joan de D\u00e9u Dr. Francesc Palau Mart\u00ednez Director Institut de Recerca Sant Joan de D\u00e9u Dr. Rafael Artuch Iriberri Deputy director, Institut de Recerca Sant Joan de D\u00e9u Dr. Jaume P\u00e9rez Payarols Director of Innovation and Research, SJD Barcelona Children's Hospital Dr. Alexandre Recerca Polit\u00e8cnica de Catalunya Dr. Mar\u00e7al Pastor-Anglada Director, Institut de Biomedicina - Universitat de Barcelona (IBUB) Dr. Carles Escera i Mic\u00f3 Delegate, Institut de Neuroci\u00e8ncies - Universitat de Barcelona (UBNeuro) Dr. Josep M. Haro Abad Director of Research, Innovation and Teaching, Parc Sanitari Sant Joan de D\u00e9u Mr. Emili Bargall\u00f3 Angerri Director, Fundaci\u00f3 de Recerca Sant Joan de D\u00e9u Ms. J\u00falia Ribot Ballabriga Scientic Manager, Institut de Recerca Sant Joan de D\u00e9u Dr. Montserrat Vendrell i Rius Partner. Alta Life Sciences (President) Dr. Antonio L. Andreu Scientific director. European infrastructure for translational medicine (EATRIS) Dra. Maria A. Blasco Director. Centro Nacional de Investigaciones Oncol\u00f3gicas (CNIO) Dr. Jordi Cam\u00ed i Morell Director. Parc de Reserca Biom\u00e8dica de Barcelona & Fundaci\u00f3 Pasqual Maragall Dra. Marisol Montolio Scientific director. Duchenne Parent Project, Spain Dr. Michael B. King London's Global University. Division of Psychiatry Dr. Carlos Rodr\u00edguez-Galindo Executive vice-president. St. Jude Children's Research Dra. Maithe Tauber Hospital Paediatric endocrinologist. Institut des Sciences du Cerveau, de la Cognition et du Comportement de Toulouse (ISC3T) Board of trustees Executive Committee Institut de Recerca Sant Joan de D\u00e9uScientic Advisory Council 6 ANNUAL SCIENTIFIC REPORT 2021 \u00b7 INSTITUT DE RECERCA FOREWORD President Dr. Rafael Artuch Vocals Dra. Esther Camprod\u00f3n Rosanas Dr. Carles Escera Mic\u00f3 Dra. Maria Dolores G\u00f3mez Roig Dra. Lourdes Ib\u00e1\u00f1ez Toda Dr. Josep Jim\u00e9nez Chillar\u00f3n Dra. Cinzia Lavarino Dr. \u00c1ngel Montero Carcaboso Dra. Carmen Mu\u00f1oz Almagro Dr. Francesc Palau Mart\u00ednez Dr. Mar\u00e7al Pastor Anglada Dra. Al\u00edcia Casals Gelp\u00ed Dra. Cecilia Jim\u00e9nez-Mallebrera Dr. Cristian Launes Montana Dr. Oriol Mart\u00edn Sol\u00e9 Dra. Alexandra Avgustinova Dra. Marta Camprub\u00ed Camprub\u00ed yo Benito Secretary Ms. J\u00falia Ribot BallabrigaResearch commission 7 ANNUAL SCIENTIFIC REPORT 2021 \u00b7 INSTITUT DE RECERCA FOREWORD Global numbers 2021 720 RESEARCH STAFF 59 Group leader 280 Staff researcher 78 Postdoc - Competitive autonomic projects 236 Competitive national projects 58 Competitive international projects 10 Non competitive autonomic projects 100 Non competitive national projects 15 Non competitive international projects 645 PUBLICATIONS Articles & reviews published in scholarly journals indexed in the ISI Web of Science 3581 Factor 64% Publications in first quartile 115 Phase III 8 Phase IV 11 Other clinical trial 91 Observational studies * Thousand of euros8 ANNUAL SCIENTIFIC REPORT 2021 \u00b7 INSTITUT DE RECERCA FOREWORD Global numbers 2015-2021 RESEARCH STAFF BUDGET *321 2015 483 2016 552 2017 514 2018 594 2019 688 2020 720 2020 2015 5.2 2016 6.5 2017 7.9 2018 9.2CLINICAL TRIALS & OBSERVATIONAL STUDIES 2015 132 2016 124 2017 140 2018 147 2019 222 2020 231 2021 321PROJECTS 2015 251 2016 303 2017 360 2018 378 2019 470 2020 486 2021 506 PUBLICATIONS 2015 302 (1138 IF) 2017 401 (1909 IF) 2018 443 (2287 IF) 2019 469 (2260 IF) 2020 590 (2652 IF) 2021 645 (3581 IF)2016 376 (1442 IF)2019 10.9 2020 12 2021 13 * Thousand of euros9 ANNUAL SCIENTIFIC REPORT 2021 \u00b7 INSTITUT DE RECERCA Fundaci\u00f3 de Recerca Sant Joan de D\u00e9u is awarded with the logo \"HR Excellence in research\" since 2018. it has commitment to implement the European Charter for Researchers and the Code of Conduct for the Recruitment of Researchers (Charter & Code) in their policies and practices. The Institut de Recerca Sant Joan de D\u00e9u (IRSJD) has been recognized by the board of trustees of the Institution for Research Centers in Catalonia (CERCA) as a CERCA centre in 2020 This award involves the development of a frontier research aimed at the scientific and economic impact and the improvement of the social and individual wellbeing. The CERCA institute focuses its actions on the contribution to the international presence of research centres from Catalonia and to promote the cooperation and scientific exchange with the top centres and universities worldwide. Moreover, it promotes the adoption of joint policies in research management, scientific development and knowledge transfer. Also, it works in order to increase and ease knowledge transfer in the business sector and general public, promoting the involvement of these agents in the field of research.HRS4R award CERCA 1 FOREWORD Governance and structures Global numbers 2020 Global numbers 2020-2015 Institutional awards 2 STAFF Research staff11 ANNUAL SCIENTIFIC REPORT 2021 \u00b7 INSTITUT DE RECERCA STAFF Research staff 720 240 men (33%) 31 men (53%) 115 men (41%) 31 men (26%)24 men (31%) 40 men (22%)59 RESEARCHERS479 women (67%) 28 women (47%) 165 women (59%) 89 women (74%)54 women (69%) 143 women (78%) 1 FOREWORD Governance and structures Global numbers 2020 Global numbers 2020-2015 Institutional awards 3 PROJECTS AND CLINICAL TRIALS New projects New DE RECERCA PROJECTS AND CLINICAL TRIALS New projectsActive projects 145 116 comptetitive 19 comptetitive 64 comptetitive 33 comptetitive23 INTERNATIONAL 86 NATIONAL 36 AUTONOMIC29 non comptetitive 4 non comptetitive 22 non comptetitive 3 comptetitive506 381 comptetitive 58 comptetitive 236 comptetitive 87 comptetitive73 INTERNATIONAL 336 NATIONAL 97 AUTONOMIC125 non comptetitive 15 non comptetitive 100 non comptetitive 10 non comptetitive 14 ANNUAL SCIENTIFIC REPORT 2021 \u00b7 INSTITUT DE RECERCA Global numbers 2020 Global numbers 2020-2015 Institutional awards 4 SCIENTIFIC PRODUCTION AND RESULTS Scientific factor journals Patents, spin-offs ANNUAL SCIENTIFIC REPORT 2021 \u00b7 INSTITUT DE RECERCA SCIENTIFIC PRODUCTION AND RESULTS Scientific publications Output Total IF Mean IF %Q1 %D1 Article 662 3440 5.5 64% 22% Editorial material 7 25 3.6 0% 0% Letter 22 173 7.9 68% 21% Review 23 141 6.1 83% 0% Others 40 365 9.1 72% 25% Total 714 4143 5.8 64% 14% 17 ANNUAL SCIENTIFIC REPORT 2021 \u00b7 INSTITUT DE RECERCA SCIENTIFIC PRODUCTION AND RESULTS Highest impact factor journals Journal Total articles 1 53,440 LANCET ONCOLOGY 1 41,316 HEART 26,481 1 25,071 LANCET DIGITAL HEALTH 1 24,519 JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 1 24,093 LANCET PUBLIC HEALTH 1 21,648 JAMA PSYCHIATRY 1 21,596 LANCET HAEMATOL 1 18,959 CIRCULATION RESEARCH 1 17,367 ACTA NEUROPATHOLOGICA 17,088 14,919 CLINICAL INVESTIGATION 1 14,808 BIOACTIVE MATERIALS 1 14,593 JOURNAL OF EXPERIMENTAL MEDICINE 1 14,307 JOURNAL FOR IMMUNOTHERAPY OF CANCER 1 SCIENTIFIC REPORT 2021 \u00b7 INSTITUT DE RECERCA SCIENTIFIC PRODUCTION AND RESULTS Journal Total articles IF LANCET CHILD & ADOLESCENT HEALTH 2 11,288 ADDITIVE 2 NUTR 1 8,701 METABOLISM-CLINICAL EXPERIMENTAL 1 1 J 1 8,262 ENVIRON POLLUT 1 8,071 JOURNAL OF SCIENCE & 1 8,067 PLOS BIOLOGY 1 8,029 OBSTETRICS 1 7,196Highest impact factor journals19 ANNUAL SCIENTIFIC REPORT 2021 \u00b7 INSTITUT DE RECERCA SCIENTIFIC PRODUCTION AND RESULTS Journal Total articles IF JOURNAL OF SPORT AND HEALTH SCIENCE 1 7,179 PEDIATRICS 2 7,125 ANALYTICAL SCIENCES1 6,053 BMJ GLOBAL HEALTH 2 5,558 JOURNAL OF MEDICAL INTERNET RESEARCH 2 5,428 MED SCI SPORT EXER 1 5,411 BRITISH JOURNAL OF GENERAL PRACTICE 1 5,386 AUTISM RESEARCH 1 5,216 DEVELOPMENTAL SCIENCE 1 5,131 ADVANCED 1 3,187Highest impact factor journals20 ANNUAL SCIENTIFIC REPORT 2021 \u00b7 INSTITUT DE RECERCA SCIENTIFIC PRODUCTION AND RESULTS Original article Journal IF Program Rives S. CAR T cells in CNS-relapsed S, S\u00e1nchez D, Mart\u00ednez L, Garc\u00eda I, Ramon M, Tondo M et al. Increasing breast polygenic Rare Diseases Esteve A, Anton J, Pino RM, S\u00e1nchez J, Fumad\u00f3 V, Fortuny C et al. Similarities and CLINICAL INVESTIGATION14,808 Esteve A, Anton J, Pino RM, S\u00e1nchez J, Fumad\u00f3 V, Fortuny C et al. Similarities and C, C\u00f3rdoba LC, Buxadera J, Marquina A, Jim\u00e9nez E, Ginebra MP et al. Zn-Mg and Zn-Cu alloys for Ruperez Ferrer G, Cervera A, Florit L, Guitart M, Garrabou G et al. Ginebra MP, Canal C. Evaluation of the effects of cold atmospheric Bonini M, Brough HA, Chivato T, Del Giacco SR et Nistal JF, Vazquez M. Sirtuins: To Be or Not To in Diabetic Cardiomyopathy. Schieber R, Raymond Y, S\u00e9gry B, Sabat\u00e9 R, Kolandaivelu K et al. SCIENTIFIC REPORT 2021 \u00b7 INSTITUT DE RECERCA SCIENTIFIC PRODUCTION AND RESULTS Original article Journal IF Program Raymond Y, Thorel E, Liversain M, Riveiro A, Pou J, L, Shin JI, Ghayda RA, Hijaz A, Sheyn D, Pope R et Smith L, E, Molero M, Wassenberg T, Peters T, Molero M, Wassenberg T, Peters H, Reyes L, Noureddine F, Ada Cavalcanti E, Ginebra MP et MATERIALS9,933 Health AR, Dom\u00ednguez C, Ortez CI, Jain M, Mebrahtu A et al. E, Fumad\u00f3 V, Henares D, Fern\u00e1ndez de Sevilla M et al. Susceptibility to Severe Acute Respiratory A Seroprevalence Study of Family Households in the Barcelona M, Gonc\u00c9 A, Fortuny C, Salazar L, Valenzuela BI et al. Cardiac Remodeling and Hypertension 2021 \u00b7 INSTITUT DE RECERCA SCIENTIFIC PRODUCTION AND RESULTS Original article Journal IF Program Brotons P, Launes C, Buetas E, Fumad\u00f3 V, Henares D, Fern\u00e1ndez de Sevilla M et al. Susceptibility to Severe Acute Respiratory A Seroprevalence Study of Family Households in the Barcelona Radua J, Soriano C, G\u00f3mez A, Porta D, Marta R et al. Structural brain correlates in major C, Alonso S, Fern\u00e1ndez de Sevilla M, Vidal M, Jim\u00e9nez A, Pons G et al. Antibody conversion rates to SARS-CoV-2 in saliva from children attending schools in Barcelona, BMC Med. 2021;19(1):309-309. IF:8,775. (Q1).BMC MEDICINE 8,775 Neuroscience Doba\u00f1o C, Alonso S, Fern\u00e1ndez de Sevilla M, Vidal M, Jim\u00e9nez A, Pons G et al. Antibody conversion rates to SARS-CoV-2 in saliva from children attending schools in Barcelona, C, Alonso S, Fern\u00e1ndez de Sevilla M, Vidal M, Jim\u00e9nez A, Pons G et al. Antibody conversion rates to SARS-CoV-2 in saliva from children attending schools in Barcelona, Spain. BMC Med. 2021;19(1):309-309. IF:8,775. (Q1).BMC MEDICINE 8,775 I, Perales A, Melchor JC, Melchor I, Marcos B et al. Placental growth factor testing in the management of late preterm preeclampsia without severe Montoya C, Ruiz E et al. Circulating Cell-Free Mitochondrial DNA C, Ruiz E et al. Circulating Cell-Free Mitochondrial DNA AJ, Badosa MC, Codina A, Montoya C, Ruiz E et al. Circulating Cell-Free Mitochondrial DNA \u00b7 INSTITUT DE RECERCA SCIENTIFIC PRODUCTION AND RESULTS Original article Journal IF Program Afia AB, Vila \u00c8, MacDowell KS, Ormazabal A, Leza JC, Haro JM et al. Kynurenine Health and Society Afia AB, Vila \u00c8, MacDowell KS, Ormazabal A, Leza JC, Haro JM et al. Kynurenine mental disorders Afia AB, Vila \u00c8, MacDowell KS, Ormazabal A, Leza JC, Haro JM et al. Kynurenine Fern\u00e1ndez D, Gin\u00e9 I, Liu I, Yucel R, Nai M, Morena M et al. Are environmental pollution and biodiversity levels associated to the Rodriguez A, Punset M, Calero JA, Javier F, Rup\u00e9rez E, Manero metallurgy with space holder for J Mater Sci Technol. 2021;76:129-149. IF:8,067. (Q1).JOURNAL OF MATERIALS SCIENCE & TECHNOLOGY8,067 Health Technologies and Innovation Ferrer G, Guitart M, Ruperez CH, MATIAS R, F\u00e0tima B, Villarroya F et al. protective JM, Stickley Koyanagi A. Relationship orientation in Med. 146. IF:7,723. (Q1).PSYCHOLOGICAL MEDICINE7,723 Mental Health and Society Gonzalez E, Grau L, Ferrero SI, Hernandez A, Rebollo M, G\u00f3mez M et al. Pessary for Management of E, Grau L, Ferrero SI, Hernandez A, Rebollo M, G\u00f3mez M et al. Pessary for Management of FM, Pertierra A, Martinez JM al. 2021 \u00b7 INSTITUT DE RECERCA SCIENTIFIC PRODUCTION AND RESULTS Original article Journal IF Program Meler E, Mazarico E, Eixarch E, Gonzalez A, Peguero A, Martinez J et al. YT, Gin\u00e9 I, Prina M, De La Fuente J et al. Development of a common scale for measuring healthy ageing across 2021;50(3):880-892. IF:7,196. (Q1).INTERNATIONAL JOURNAL OF EPIDEMIOLOGY7,196 Mental Health and Society Barranco M, Sol\u00e0 P, Picart S, Kanaan S, Fonollosa J, Canal C. Quantification of Plasma-Produced Hydroxyl Radicals in Solution Puiggal\u00ed A, Roa JJ, Ginebra MP, Jos\u00e9 C. A, Perera Morillo D, Haro JM, Olaya B, Lara E, Maria M. Changes in depression and suicidal ideation under severe lockdown restrictions during the first wave of the COVID-19 pandemic in Spain: a longitudinal study in the 2021;30:1-27. IF:6,892. (Q1).EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES6,892 Health and Society Cabello M, Rico LA, Martinez JC, S\u00e1nchez A, Caballero FF, Borges G et al. The role of ageing in the wish to be dead: disentangling age, period Society Jacob L, Kostev K. Osteoarthritis and the incidence of fracture in H\u00e4m\u00e4l\u00e4inen J, Astikainen Gonzalez A, Youssef L et al. Added prognostic 2021 \u00b7 INSTITUT DE RECERCA SCIENTIFIC PRODUCTION AND RESULTS Original article Journal IF Program Paredes AJ, Cesar S, Montero R, Latre C, Genov\u00e9s J, Martorell L et al. Plasma AJ, Cesar S, Montero R, Latre C, Genov\u00e9s J, Martorell L et al. Plasma Montero R, Latre C, Genov\u00e9s J, Martorell L et al. Plasma C, Navarro M, Adri\u00e1n A, L\u00f3pez Y, Garcia J, Montero J. Effectiveness of mindfulness-based stress reduction Health and Society Smith L, Il J, McDermott D, Jacob L, Barnett Y, L\u00f3pez GF et al. Association between food insecurity and Felez M, Bort J, Ma R, Romano E, Faires M, Stubbs B et al. Light- intensity physical activity mental ill health: a systematic review of observational in AND PHYSICAL ACTIVITY6,457 Mental Health and Society Aznar I, Zabaleta E, Casajuana M, S\u00e1nchez A, Parody E, Bol\u00edbar B et al. Cost-effectiveness analysis of a multiple health behaviour change intervention in people aged between 45 and 75 years: a cluster randomized controlled trial in primary PHYSICAL ACTIVITY6,457 Mental Health and Society Garc\u00eda A, Buendia M, Dey\u00e0 A, Lozano J, Serrano M, Van Den A RYM et al. Novel PGM3 compound heterozygous Garc\u00eda A, Buendia M, Dey\u00e0 A, Lozano J, Serrano M, Van Den A RYM et al. Novel PGM3 compound heterozygous ANNUAL SCIENTIFIC REPORT 2021 \u00b7 INSTITUT DE RECERCA SCIENTIFIC PRODUCTION AND RESULTS Original article Journal IF Program Garc\u00eda R, Gavalda A, Villarroya F, Marfany Rodr\u00edguez J, L\u00f3pez M, Hadley S, Cavia M, Mu\u00f1iz P et al. Effects of Hypothermia and Allopurinol on Oxidative Status L\u00f3pez J, Prades L, Roig F, Castells A et al. Sex-Specific Protective Effects e2 on 2021;76(1):41-49. Martinez A, Bekele D, Sabariego C, Rodr\u00edguez \u00c1, Vorstenbosch E, Rico LA et al. The Structural and and Society Santini ZI, Koyanagi A, Stewart S, Perry BD, Marmot M, Koushede V. Cumulative risk of compromised physical, mental and social health in adulthood due to family conflict and financial strain during childhood: a retrospective Health and Society Tyrovolas S, Gin\u00e9 I, Fern\u00e1ndez D, Morena M, Koyanagi A, Janko M et al. Estimating the Internet Res. 2021;23(6)IF:5,428. (Q1).JOURNAL OF MEDICAL INTERNET RESEARCH5,428 Mental Health and Society Castells A, Roig F, Lamonja N, Tor\u00e1n P, Pera G, Montero P et al. Sex Matters in the Association between Physical Activity and Fitness with Cognition. Med Calvo MJ, Cubells M et al. PLXNA2 and LRRC40 as candidate in autism RES. IF:5,216. (Q1).AUTISM RESEARCH 5,216 Precission Medicine Rare Diseases Fran\u00e7ois C, Rodriguez A, Teixid\u00f3 M, Agut T, Bosch L. Attenuated brain M, Barajas A, del Cacho N et al. Depressive symptoms and their relationship with negative and other Society Calderon M, Vila R, Dolz M, Butjosa A, Barajas A, del Cacho N et al. Depressive symptoms and their relationship with negative and other mental disordersHighest impact factor journals27 ANNUAL SCIENTIFIC REPORT 2021 \u00b7 INSTITUT DE RECERCA SCIENTIFIC PRODUCTION AND RESULTS Original article Journal IF Program Zer\u00f3n MF, Carpio TV, Estrella G, D\u00edez A, Cambras T, Alda JA et al. ADHD subtypes are with circadian rhythms of motor activity, sleep disturbances, and body mass index in children and adolescents: a case-control study. Eur Dolz M, Butjosa Barajas A, del Cacho N et al. Depressive symptoms and their relationship with negative and other J, Arca G, Agut T, Alarcon A, Mart\u00edn A et al. Development, Reliability, and Testing of a New Rating Scale Mart\u00ednez A, Baquero F, Santiago B, Fortuny C, M\u00e9ndez A, Del Rosal T et al. Interferon-Gamma Release Assays Differentiate between Mycobacterium Velilla M, Teresa M, Balcells C, Herranz A, Sin M et al. Lung Ultrasound in Bronchopulmonary M, Teresa M, Balcells C, Herranz A, Sin M et al. Lung Ultrasound in Bronchopulmonary K, Schnitzler A, Haro JM, Koyanagi Sexual Orientation journals28 ANNUAL SCIENTIFIC REPORT 2021 \u00b7 INSTITUT DE RECERCA SCIENTIFIC PRODUCTION AND RESULTS Patents, utility models and spin-offs Elemento de fijaci\u00f3n de dispositivos a nivel craneal para neonatos Country: Spain Number: EP3368044 Inventors: Nuria Carrera Barcelona Peptidic Conjugates useful and Angel Montero Carcaboso Propietors: Hospital Sant Joan de D\u00e9u Barcelona, Fundaci\u00f3 Privada Institut de Recerca Biom\u00e8dica de Barcelona and Universitat de Barcelona V\u00e1lvula para respiradores (PEEP) Country: Germany and Europe Number: 2021042107265100DE and EP213823131 Enric Palau Forte, Arnau Valls Esteve, Mart\u00ed Pons Odena, Carlos Alaez Vasconcellos, Lluis Font Vizcarra, Adrian Berm\u00fadez Castel, Xoel Pena P\u00e9rez, Marc Murcia Laguna Propietors: Hospital Sant Joan de D\u00e9u Barcelona Tratamiento de la enfermedad de Charcot-Marie-Tooth Country: Spain Number: P202130576 Inventors: Jose Manuel Palau Mart\u00ednez, Jorgina Satrutegui Gil-Delgado Propietors: Hospital Sant Joan de D\u00e9u Barcelona, Fundaci\u00f3n General de la Universidad Aut\u00f3noma de Madrid and Centro de Investigaci\u00f3n Biom\u00e9dica en Red (CIBER) V\u00e1lvula para dispositivos de ventilaci\u00f3n (VENTURI) Country: Francis de Zegher and Lourdes Ib\u00e1\u00f1ez Propietors: Hospital Sant Joan de D\u00e9u Barcelona and University Leuven Kath Treatment of hepatic and or visceral fat excess Country: Spain Number: P2021382313 Inventors: Lluis Font Vizcarra, Arnau Valls Esteve, Carlos Alaez Vasconcellos and Mart\u00ed Pons Propietors: Hospital Sant Joan de D\u00e9u Barcelona GD2 Administration Carles Ler\u00edn and Marta Ram\u00f3n Propietors: Hospital Sant Joan de D\u00e9u Barcelona Treatment of hepatic steatosis related oligo-ovulation Francis de Zegher and Lourdes Ib\u00e1\u00f1ez Propietors: Hospital Sant Joan de D\u00e9u Barcelona and University Leuven Kath A medical ventilator system and a method for predicting transient states A. Hern\u00e1ndez Propietors: Universitat Polit\u00e8cnica de Catalunya and Universidad de AntioquiaEphion Health S.l. 2021 \u00b7 https://ephion.health/ Co-funders: Eurecat, Hospital Sant Joan de D\u00e9u and The Collider Ephion Health is the platform to develop and deploy measures for patient mobility. assist complete of mobility diseases and quality of life. Ephion's technology allows to save time and resources in clinical care and clinical trials. Gate2Brain 2020 \u00b7 https://gate2brain.com/ Co-funders: Universidad de Barcelona (UB), Hospital Sant Joan de D\u00e9u (HSJD) Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers company Omadre was created to provide hospitals the tools required for the efficient management of mother's milk, increasing the safety of existing processes in this way. ABLE Human Motion 2018 \u00b7 https://www.ablehumanmotion. com/ Co-funders: Dr. Alfons Carnicero, Dr. Alex Garc\u00eda & Dr. Josep Maria Font (IRSJD) ABLE Human Motion is a medical device spin-off from Universitat Polit\u00e8cnica de Catalunya (UPC) that is developing and will commercialize robotic exoskeletons to enhance mobility and independence of people with lower-limb paralysis. We have New patents, license agreements and utility modelsPortfolio of spin-offs 29 ANNUAL SCIENTIFIC REPORT 2021 \u00b7 INSTITUT DE RECERCA SCIENTIFIC PRODUCTION AND and health complications while Genomics 2018 \u00b7 https://dbgen.com/ Co-funders: Dr. Roser Gonz\u00e0lez- Duarte and Dr. Gemma Marfany (IRSJD) DBGen is a company focused on contact with patients, ophthalmologists, and enterprises in need of its to be provided to the patient with respect to emerging therapies for genetic disorders of the eyes. Genetic case. CEBIOTEX 2012 \u00b7 http://www.cebiotex.com/ Dr. Joan Bertran Llavina (CEO) & Dr. Angel Montero (IRSJD) Cebiotex has developed and characterised at and in vivo, nonwoven nanofiber membranes for the local release of active ingredients in the local treatment of the surgical site after tumour excision surgery. The purpose of the local release of drugs is to achieve high concentrations of active ingredients in the area where the release device is placed, avoiding systemic toxicity and Cebiotex is on interaction of researchers from two Catalan institutions: the Polytechnic University of Catalonia (UPC) and Sant Joan de D\u00e9uBarcelona Children's Hospital (HSJD). BCN Innova 2008 \u00b7 http://www.bcninnova.com/ Dr. Joan Prat (IRSJD) BCN Innova, a spin-off company of Sant Joan de D\u00e9u-Barcelona Children's Hospital, has developed a device (GazeLab) diagnosis and treatment of strabismus, reducing the number of second operations that achieve the expected 1. allows objective exploration on a revolutionary level of precision, with much better results than the subjective-measurement model that has prevailed until now. 2. It provides a 50% reduction in the number of second operations, obviating those which are surgically unnecessary. Patents, utility models and spin-offs30 ANNUAL SCIENTIFIC REPORT 2021 \u00b7 INSTITUT DE RECERCA SCIENTIFIC PRODUCTION AND Lavarino and Silvia MateoJanuary Maria Julieta Gonzalez Avances en el estudio de la fenilcetonuriaUniversitat de BarcelonaJaume Campistol and Rafael ArtuchFebruary Elena generaci\u00f3 de i Wnt pathway genes in complex and monogenic of low and high bone massUniversitat de BarcelonaSusanna Balcells and Daniel GrinbergMarch Montserrat Bou Papel de la microbiota intestinal en el tratamiento del s\u00edndrome de Prader-WilliUniversitat de BarcelonaCarles Lerin and Marta RamonApril schizophreniaUniversitat de BarcelonaBelen Ramos March Jordina Tor Riesgo de psicosis en poblaci\u00f3n infanto-juvenil: caracter\u00edsticas cl\u00ednicas y cognitivesUniversitat de BarcelonaLuis San Molina SintesMarch in Ramos March Ivet Bay\u00e9s Mar\u00edn Estudio de enfermedades cr\u00f3nicas de salud y funcionamiento en personas de mediana edad y mayores desde una perspectiva epidemiol\u00f3gicaUniversitat de BarcelonaBeatriz Olaya and Josep Maria HaroMay31 ANNUAL SCIENTIFIC REPORT 2021 \u00b7 INSTITUT DE RECERCA SCIENTIFIC AND de CatalunyaRa\u00fcl Ben\u00edtez and Leif Hove MadsenMay Laura Almeida Modelo de s\u00edndrome alcoh\u00f3lico fetal en rat\u00f3n seg\u00fan dos patrones de consumo humano y el papel de la epigalocatequina galato en su prevenci\u00f3n. estudio de biodisponibilidad de la epigalocatequina galato en humanosUniversitat de BarcelonaV Andreu (buscar) and un hospital infantil de tercer nivellUniversitat de BarcelonaAntoni Noguera June Sara Bobillo Utilidad de los biomarcadores en la respuesta inflamatoria sist\u00e9mica y en la implementaci\u00f3n de algoritmos de manejo de la antibioticoterapia en los pacientes cr\u00edticos pedi\u00e1tricosUniversitat de BarcelonaIolanda Jordan and Bernardo S\u00e1nchez de g\u00e9nero en el adolescente con conducta suicidaUniversitat Aut\u00f2noma de CatalunyaFrancisco Villar Cabeza, Mar Vila Grifoll, Mar Sintes Est\u00e9vezJuly Ester Ant\u00f3n Galido September Santiago Raymond Biomimetic Bone Grafts: from the lab to the clinicUniversitat Ginebra and Montserrat Espa\u00f1olOctoberDoctoral Theses32 ANNUAL SCIENTIFIC REPORT 2021 \u00b7 INSTITUT DE RECERCA AND Villarroya and Joan VillarroyaOctober Diego Torres Desarrollo de un nuevo proceso basado en la inyecci\u00f3n 3D de tintas con carga met\u00e1lica para fabricar pr\u00f3tesis porosas de titanio bioactivas y con propiedades antibacterianasUniversitat Polit\u00e8cnica de CatalunyaJos\u00e9 Mar\u00eda Manero, Elisa Rup\u00e9rez and Jos\u00e9 A. Calero (AMES).October AnnaHuguet Miguel Influencia de un programa de mindfulness sobre los s\u00edntomas nucleares, las funciones ejecutivas y el eje hipot\u00e1lamo-hip\u00f3fisis-adrenal (HPA), en ni\u00f1os recientemente diagnosticados de Trastorno por D\u00e9ficit de Atenci\u00f3n e Hiperactividad (TDAH). Un estudio aleatorizadoUniversitat de BarcelonaSusanna Balcells and Roser UrreiztiNovember Marley Vega Development and Applications of Neuromusculoskeletal Modeling Software for Personalized Treatment Design Rice University USA)Josep Maria Font and B.J. Fregly (Rice University)November Diaz Modulation extracelular vesiclesUniversitat Discovering new targets and opportunitiesUniversitat de numbers 2020-2015 Institutional awards 5 CORE FACILITIES34 ANNUAL SCIENTIFIC REPORT 2021 \u00b7 INSTITUT DE RECERCA CORE FACILITIES The Institut de Recerca Sant Joan de D\u00e9u makes available to its researchers a set of fundamental services and infrastructures for the performance of their projects. In order to facilitate high-level research, the IRJSD offers its professionals technical, scientific and support services as the most suitable infrastructures required Imaging Sequencing Unit Animal housing Unit of Desing, Analysis and Int erpretation of data (DAIOmics) Management support services Administration Human and communication Core facilities 1 FOREWORD Governance and structures Global numbers 2020 Global 2020-2015 6 TRAINING, COMMUNICATION and public 2021 DE RECERCA COMMUNICATION AND PARTICIPATION 22 SEMINARS Relation of Biomedicina: on estem actualment? Dr. Llu\u00eds Montoliu, CSIC Centro Nacional 9 FEBRUARY Microbiota en l'entorn maternal- infantil: rellev\u00e0ncia per a la salut Dra. Mar\u00eda Carmen Collado. CSIC Institut d'Agroqu\u00edmica i Tecnologia d'Aliments ratol\u00ed segons dos patrons de consum hum\u00e0 i el paper de la EGCG en la seva prevenci\u00f3 Dra. Laura Almeida, IRSJD 27 FEBRUARY Nano Rare Disease Day 2020 Organise: Nanomed with IBEC & IRSJD IRSJD 30 MARCH Impacte emocional i de la conducta de la pand\u00e8mia COVID19 en poblaci\u00f3 infanto-juvenil Dra. Esther Via & Dr. Xavier Estrada, IRSJD 13 APRIL Detecci\u00f3 de in the mammalian retina Dra. Serena Mirra, IRSJD. 11 MAY Role of Wnt pathway genes in complex and monogenic phenotypes of low and high bone mass Dra. N\u00faria Mart\u00ednez Gil, IRSJD 25 MAY The spectrum of COVID-19 in pregnancy Dra. Rosalia Pascal, IRSJD, & Dra. Francesca Crovetto (IDIBAPS) 15 JUNE Prevalen\u00e7a i factors explicatius de la no iniciaci\u00f3 pedi\u00e0trica i en de la no iniciaci\u00f3 pedi\u00e0trica en antibi\u00f2tics i medicaments de salut mental Cristina Carbonell, IRSJD, & Alba S\u00e1nchez, IRSJD 29 JUNE Addressing Clinical Dr. Juan Vicente JULY Gas Plasma technology in Osteosarcoma: advances of a novel selective novel its application in Pediatric Dra. Soledad IRSJD 28 SEPTEMBER Simulation of Motion with York. USA 19 OCTOBER Efecte de la nicotinamida, la forma amida de la B3, contra el desenvolupament d'obesitat Dr. La no del tractament farmacol\u00f2gic de la dels pacients i els professionals M\u00aa Teresa Pe\u00f1arrubia-Maria, primer episodis DECEMBER with neurodevelopmental disorder (ASD) and healthy controls with Body Mass Index (BMI) and an altered chronotype Ares Sentenach, IRSJD37 ANNUAL SCIENTIFIC REPORT 2021 RECERCA COMMUNICATION AND PARTICIPATION IN 2021 250 ATTENDEES IN To promote the development of the different competence dimensions, four types of training modalities are established: Knowl tr paragraphs and sentences in english Organitzaci\u00f3 i ges ti\u00f3 del temps Est ad\u00edstica Writing Retreat (2ed) Per qu\u00e8 \u00e9s Rec erca Sensbilizaci\u00f3n en materia de igualdad Visibilidad y divulgaci\u00f3n de la actividad inves tigadoraTraining programme38 ANNUAL SCIENTIFIC REPORT 2021 \u00b7 science Europeans Resear cher's Night Setamana de la Ci\u00e8ncia Fes la Ci\u00e8nciaInternet and Social media public 39 ANNUAL SCIENTIFIC REPORT 2021 \u00b7 INSTITUT DE RECERCA TRAINING, COMMUNICATION AND PARTICIPATION January We have seen that in mouse models, malnutrition during lactation is associated with alterations in the metabolism adult. (Photo assess the effects of the pandemic on mental health. A study analyses the risk genetic factors shared between ADHD and disruptive behaviour disorders. (Photo 2) March The conditions 70% pain have newborn's A new facial recognition tool could make it easier for people with schizophrenia to socialize. May They draw a \"map\" of the enteroviruses that cause hand-foot- and-mouth disease in our country. Mutations in the GEMIN5 gene as the origin of rare genetic disorders in boys and girls. June The CERKL gene mitochondrial regulation of retinal tumour in mica. (Photo 6) 6% of Europeans suffer from depression. (Photo 7)News 7 6 1 2 43 540 ANNUAL SCIENTIFIC REPORT 2021 \u00b7 INSTITUT DE RECERCA TRAINING, COMMUNICATION AND Lourdes Iba\u00f1ez treatment August Study the associated with the appearance of depression during confinament. IRSJD'researchers the concentration of chemical placenta with fetal growth. (Photo 8) September Researchers describe a pathway early could help reduce the impact of sudden infant death. October A in drug research. (Photo 10) Institut de Recerca Sant Joan de D\u00e9u is holding its 3rd Scientific Conference. (Photo 11) November Brown adipose tissue activity is higher in girls during project SARAS, towards cognitive end. Measuring antibodies in saliva is a adolescents with early onset psychosis suffer from clinical depression.News 8 9 10 117 SCIENTIFIC ACTIVITY 7.1. MEDICINE AND PEDIATRIC SCIENCE AREA 7.2. MENTAL HEALTH AREA 7.3. TRANSVERSAL PROGRAM1 FOREWORD Governance and structures Global numbers 2020 awards 7.1.1 Neuroscience7.1 MEDICINE adolescent mental health43 INSTITUT DE RECERCA MEDICINE AND PEDIATRIC SCIENCE Benito PHD STUDENTS Cristina Jou Mu\u00f1oz ASSISTANT RESEARCHER Ana Pareja Bosch, Sonia Segovia Simon, Jessica Maria Exposito Escudero, Laura Carrera Garc\u00eda, Maria del Carmen Badosa Gallego TECHNICIAN Ana Codina Bergad\u00e0 in reallife conditions for patients with Duchenne muscular dystrophy and spinal muscular atrophy. (561/C/2020). Fundaci\u00f3 La Marat\u00f3 de TV3. 2021-2024. IP: Daniel Natera de Benito. Medicina Per sonalizada para las Distrofias Musculares Cong\u00e9nitas: Desarrollo de terapias avanzadas, modelos fisiol\u00f3gicos y herramientas diagn\u00f3sticas precisas. (PI19/00122). Instituto de Salud Carlos (ISCIII). Estudio abierto para evaluar la seguridad, la t olerabilidad y la eficacia de viltolars\u00e9n en ni\u00f1os con distrofia muscular de Duchenne (DMD), capaces e incapaces de caminar. A Phase 2 Openl-label Study to Assess the Safety, Tolerability, and Efficacy of Viltolarsen in Ambulant and Non-Ambulant Boys with Duchenne Muscular Dystrophy Estudio de F ase 4 de Nusinersen (BIIB058) en Pacientes con Andr\u00e9s Nascimento Osorio. Estudio de e xtensi\u00f3n de fase 3, multic\u00e9ntrico y abierto, para evaluar la eficacia y la seguridad de viltolars\u00e9n en ni\u00f1os con distrofia muscular de Duchenne (DMD) capaces caminar. Osorio. SELECTED PUBLICATIONS L\u00f3pez A, Carrasc o C, Fern\u00e1ndez C, Santisteban P. Unraveling the Nater a D, Aguilera S, Costa L, Garc\u00eda M, Miranda MC, R\u00fabies J et al. COVID-19 in children with neuromuscular Neurol. 2021;268(9):3081-3085. Ortez CI, Jain M, Mebrahtu A et al. Montoya C, Ruiz E et al. Circulating Cell-Free Mitochondrial DNA the course of 2021, we have been able to advance characterisation of various significant aspects of neurotransmitter disorders. This was possible thanks to the collaboration of many different centres through the international network I-NTD. Likewise, we carried out our own clinical trial with L-serine on patients with mutations due NMDA receptors. We also concept test of the \"Neuroprotect\" formula designed in our laboratory, which has the research personnel. With the help of we seek to develop and/or apply Roser Colom\u00e9 Roura, Silvia Maria Meavilla Olivas, Alejandra Darling, Jordi Muchart L\u00f3pez, M\u00aadel Mar O'Callaghan Gordo, Federico Ramos, Anna L\u00f3pez Sala, Maria del Carme Fons Estupi\u00f1a POSTDOC ASSOCIATED RESEARCHERS Alba Tristan Noguero, Alfonso Luis De Oyarzabal Sanz PHD STUDENTS Juliana Ribeiro Constante, Noelia 44 INSTITUT DE RECERCA MEDICINE AND PEDIATRIC SCIENCE AREA NEUROSCIENCE Rivera S\u00e1nchez, TREAT-AHC. Identification of c ompounds for the treatment of Alternating of Childhood Estudio de la eficacia y seguridad de v atiquinona en el tratamiento de la epilepsia farmacorresistente en pacientes con enfermedad mitocondrial. Efficacy and Safety Study of Vatiquinone for the Treatment of f ase 3, multic\u00e9ntrico, aleatorizado, doble ciego, de grupos paralelos y controlado con placebo, para evaluar la seguridad, la tolerabilidad y la eficacia de 2000 mg/kg de Trappsol\u00ae Cyclo\u00e2\u00a2 (hidroxipropil-\u00ce\u00b2-ciclodextrina) y tratamiento est\u00e1ndar comparado con placebo y tratamiento est\u00e1ndar en pacientes con la enfermedad de Niemann-Pick de tipo C1. A Phase III, Double-blind, Efficacy of 2000 mg/kg of Trappsol\u00ae Cyclo\u00e2\u00a2 (Hydroxypropyl-\u00ce\u00b2-cyclodextrin) and Standard of Care Compared to Placebo and Standard of Care in Patients Gordo. Estudio al eatorizao, de grupos paralelo, doble ciego, controlado con placebo, con extensi\u00f3n abierta, para evaluar la eficacia y la seguridad del vatiquinona para el tratamiento de la ataxia de Friedreich (MOVE-FA). A randomized, parallel-arm, double- blind, placebo-controlled study with extension to assess the safety and efficacy of vatiquinone for the treatment of friedreich ataxia. (PTC743-NEU-003). CTI Clinical Trial & consulting services PTC Therapeutics, Inc. 2021-. PI: Alejandra Darling. Oyarzabal AL, Musokhranova U, Barr os Yildiz Y, Mastrangelo M, Pons R et al. Insights into expanding DE RECERCA MEDICINE AND PEDIATRIC SCIENCE AREA NEUROSCIENCE Wassenberg T, Peters & Ana Alarcon Allen, MD, PhD The Neonatal Brain Group has maintained its commitment to generate knowledge on brain disorders of the foetal/neonatal period with an impact on children's health and capacities. The group was founded by Dr Alfredo Garc\u00eda-Alix and directed by succeeded as principal investigators and the group has been consolidated with the incorporation of two pre- doctoral researchers, Drs Nuria Carreras and Mar Velilla, and the paediatric and perinatal pathologist Dr S\u00edlvia Planas. The group has continued with its line of work on pathogenic mechanisms and biomarkers in neonatal hypoxic- ischaemic encephalopathy arterial infarction. Its other active primary lines are: (1) Brain maturation and assessment of (PI: Alarc\u00f3n); and (3) Care practices with neurological risk and their families (PI: Nuria Herranz). One of the most positive aspects been the continued collaboration with other specialists researchers in areas relating to foetal and neonatal neurology, and with other groups from the Sant Joan de D\u00e9u Barcelona Research Institute and from other institutions. The Group's projects have adopted several different favouring of the research in all cases. Moreover, within the sphere of our research, we continued to participate in both national and European working groups with a global teaching and research outlook. The group's achievements in 2021 included a total of 18 publications, with a total impact factor of 74.35. Likewise, Ms. neonatal that brain. Lastly, the group continued to promote pre-doctoral research, with one doctoral thesis that was presented and three in progress, in addition to three final master's degree projects. MEMBERS STAFF RESEARCHER S\u00edlvia Planas Rom\u00e1n, Nuria Herranz Rubia, Maria del mar Velilla Aparicio POSTDOC ASSOCIATED CRIB (Cribado de cit omegalovirus cong\u00e9nito en Reci\u00e9n nacidos sanos e Ingresados - Barcelona). (PI19/00095). Instituto de Salud Carlos III (ISCIII). 2020- 2024. PI: Ana Alarc\u00f3n Allen. Elaboraci\u00f3n de un atlas morfom\u00e9trico normalizado de la maduraci\u00f3n cerebral del reci\u00e9n nacido prematuro y valoraci\u00f3n del impacto de la patolog\u00eda cerebral en el proceso madurativo. (PI18/00110). Instituto de Salud Carlos III Quijano. Contrat 2019-2021. neonatal arterial La Bonafonte F, Thorne C, Peckham CS et al. Vertical transmission of Zika and outcomes: a Bayesian Rodriguez Teixid\u00f3 Agut T, Bosch L. brain Arnaez J, Ar ca G, Agut T, Alarcon A, Mart\u00edn A et al. Development, Reliability, and Testing of a New Rating Scale for Neonatal Encephalopathy. J Pediatr. 2021;235:83-91.IF:4,406. (Q1). Planas S, Cruz O, Miguel S, Albert A, Rovir a C, Bombi JA. Extra- axial sacral soft tissue giant cell ependymoma affecting a Case literature. Neuropathology. 2021;41(2):139- 145. IF:1,906. (Q3). Neuropsychology Roser 2021, our group continued to progress with the study of the neuropsychological functioning of persons with risk factors (obesity), and with projects financed in national 46 INSTITUT DE RECERCA MEDICINE AND PEDIATRIC SCIENCE AREA NEUROSCIENCE competitive calls, including the telethon La Marat\u00f3 de TV3, and we continued to hold the ICREA- Academia award, received by one of our researchers. We also continued to to European calls and we are awaiting the resolution of a COST Action in the field of cerebral palsy. Our projects and our selected publications in Q1 evidence our group's capacity to allows of disorders training. MEMBERS STAFF RESEARCHER Isabel Garc\u00eda Garc\u00eda, Maria Matar\u00f3 Serrat, Xavier Cald\u00fa Ferr\u00fas, Maria Angeles Jurado Luque POSTDOC Gallaguet, Montse Blasco Sierra, Mar\u00eda Garc\u00eda Galant, Sandra Lu\u00eds Ruiz, Xavier Prats Soteras, Noem\u00ed Lamonja Vicente, Ballester Plan\u00e9, Olga Ottino Gonz\u00e1lez TECHNICIAN Gemma Mont\u00e9 Rubio SELECTED PROJECTS Gu\u00edas basadas en la evidencia y c onsensuadas para la evaluaci\u00f3n neuropsicol\u00f3gica de las personas con par\u00e1lisis cerebral grave y par\u00e1lisis cerebral discin\u00e9tica (PID2020-117163RB-I00). Ministerio de Economia y Competitividad. Convocat\u00f2ria d'ajuts del Programa Estatal d'Investigaci\u00f3, Desenvolupament i reptes de la Societat. Reptes. 2021-2024. PI. Roser Pueyo Benito. Ajut per incentiv ar i consolidar la recerca d'excel\u00b7l\u00e8ncia ja existent a les universitats p\u00fabliques de Catalunya. Programa ICREA Academia 2018. Fundaci\u00f3 Instituci\u00f3 Catalana de Recerca en pacients amb ictus isqu\u00e8mic TV3. Ajuts econ\u00f2mics a projectes de recerca de la Fundaci\u00f3 Marat\u00f3 TV3. 2018-2022. PI: Maria Mataro Serrat. Inflamaci\u00f3n, estr \u00e9s y microbiota como mediadores entre la obesidad y el funcionamiento cerebral durante la adolescencia (PSI2017-86536-C2-1-R) Ministerio de Economia y Competitividad. Convocat\u00f2ria d'ajuts del Programa Estatal d'Investigaci\u00f3, Desenvolupament i I+D+I. 2018- 2022. PI: Maria Angeles Jurado A, Roig F, Dacosta R, Lamonja N, Tor\u00e1n P, Pera G, Montero P et al. Sex Matters in the Association between Physical Activity and Fitness with Cognition. (Q1). N, Dacos ta R, L\u00f3pez J, Prades L, Roig F, Castells A et al. Sex-Specific Protective Effects e2 on (Q1). Baggio HC, Jurado MA, Segur a B, Caldu X, Prats X et al. Alterations in Brain Network Organization in Adults With Obesity as with the Foetal Environment and Obstetric Complications research group, led by Dr G\u00f3mez-Roig, for of childhood. We have published two significant studies on this subject: one proposing a mature and of others which are not yet mature (Arenillas-Alc\u00f3n et al. , 2021); and a protocols required the neonatal FFR (Lemos et al. , 2021). These two publications open the way for the mass monitoring of the cerebral maturation allowing language processing in newborns. A third significant study conducted in this study is very important since it reveals the basis for the use of FFR as a biomarker for language acquisition in to indicator. Other studies have also been promoted in which we will be making use of brain signals associated with prediction with neurodevelopment AREA MEMBERS STAFF RESEARCHER Jordi Costa Faidella, Imma Clemente Lapena, Maria Jos\u00e9 Corral L\u00f3pez, Maria Isabel N\u00fa\u00f1ez Pe\u00f1a, Iria San Miguel Ins\u00faa, Hans Sup\u00e8r, Marc Via Garcia PHD STUDENTS Sonia Arenillas Alc\u00f3n, Marta Puertollano Rodr\u00edguez, Teresa Ribas Prats, Alejandro Lerer SELECTED PROJECTS Ajut per incentiv ar i consolidar la recerca d'excel\u00b7l\u00e8ncia ja existent a les universitats p\u00fabliques de Catalunya. Programa ICREA Academia 2020. Fundaci\u00f3 Instituci\u00f3 Catalana de Recerca del espectro alcoh\u00f3lico fetal (TEAF): Identificaci\u00f3n precoz y biomarcadores de riesgo para alteraciones neurocognitivas mediante el potencial de seguimiento de frecuencia (PSF). Fundaci\u00f3n Alicia Koplowitz. Convocatoria de Ayudas a Proyectos de Investigaci\u00f3n en el \u00e1rea de Psiquiatr\u00eda de la Infancia y Adolescencia y Neurociencias en el Ni\u00f1o. 2020-2022. PI: Carles Escera. Caract erizaci\u00f3n de la respuesta de seguimiento de frecuencia (RSF) en reci\u00e9n nacidos como posible biomarcador de desarrollo neurocognitivo (PGC2018-094765- B-I00). Ministerio de Ciencia, Innovaci\u00f3n y Universidades. Convocat\u00f2ria d'ajuts del Programa Estatal de Foment de la Investigaci\u00f3 Cient\u00edfica i T\u00e8cnica d'Excel\u00b7l\u00e8ncia. Subprograma art soundscapes and the 20218-2024. PI: Carles Escera. SELECTED PUBLICATIONS Arenillas-Alc\u00f3n S, Costa J, Ribas T, G\u00f3mez MD, Esc era C. Neural encoding of voice IF:4,379. (Q1). Font-Alaminos M, Ribas T, Gorina N, Esc era C. Emergence of prediction error along the human auditory hierarchy. Hear 2021;399:107954. (Q1). (MEG) study. Neuroimage. 2021;231:117866. IF:6,556. (Q1). Lemos FA, da Sil va CK, Escera C, activity has been affected by the pandemic situation and by the change of location of the APAL group's laboratory to the facilities at Num\u00e0ncia Street. We have advanced in three directions. Firstly, in the research line on the child population with bilateral profound deafness, we completed of lexical learning and oral language level achieved (research in collaboration with the ORL unit At the same time, we assessed two groups of children with normal hearing, at 10 months and at 18-24 months, who will form the control groups of this study, which is expected to end in 2022. Preliminary data suggest differences between groups at 10 months in social cognition tasks, and a great variability in post-implant performance. These results will be analysed, taking into consideration the neuroimaging data obtained in the pre-implant period and other cognitive and communicative development variables that have been collected. We have also progressed in a second research line focused on the study of the audiovisual processing of speech from the age of 4 months in full-term and moderately premature children (the the collaboration of Dr Agut). The purpose of this research line is to analyse the impact of a bilingual/ multilingual family setting on the basic processes of recognition of the mother tongue, the association between the speaker and the speech ordinarily used, and the association between voice and speech. Lastly, we succeeded in sample full-term low- weight (SGA) children with cognitive and speech data, and with data on school performance, at the age of 7-8 years (a study in collaboration with Dr Ib\u00e1\u00f1ez's group). The preliminary results, which were presented at the 3rd Research Conference of the IRSJD, show differences between groups in the areas of attention and executive function, and minor differences in speech, which were more prominent in the phonological and articulatory domain, with a possible link to reading difficulties. We also worked on the connection between endocrine- metabolic variables and cognitive- linguistic performance, and on for catch-up patterns that may predict cognitive results the long term. MEMBERS STAFF RESEARCHER Ferran Pons Gimeno, Marta Ramon Casas ASSOCIATED RESEARCHERS sobre en nens. Fundaci\u00f3 Privada Bet\u00e0nia-Patmos. PI: Ferran Pons Gimeno. Variabilidad en el pr ocesamiento audiovisual del habla en la infancia: 48 INSTITUT DE RECERCA MEDICINE AND PEDIATRIC SCIENCE AREA NEUROSCIENCE rol de la experiencia ling\u00fc\u00edstica, maduraci\u00f3n neurol\u00f3gica y capacidad sensorial (PGC2018-097487-B-I00). Ministerio de Ciencia, Innovaci\u00f3n y Universidades. Convocat\u00f2ria d'ajuts del Programa Estatal de Foment de la Investigaci\u00f3 Cient\u00edfica i T\u00e8cnica d'Excel\u00b7l\u00e8ncia. Subprograma Ferran Pons Gimeno i Laura Bosch Galceran. Resonancia magn\u00e9tica funcional e imagen de t ensor de difusi\u00f3n en la valoraci\u00f3n prequir\u00fargica del paciente pedi\u00e1trico con hipoacusia prelingual neurosensorial profunda bilateral de detecci\u00f3n en el cribado neonatal como potenciales biomarcadores de desarrollo de lenguaje oral tras la colocaci\u00f3n de un implante coclear (PCP00215). Sociedad Espa\u00f1ola M\u00f3nica Rebollo. Garc\u00eda-Alix A, Bosch L, Rodriguez-F ornells A. Signatures of brain plasticity supporting language 2021;24(1):12990. IF:5,131. (Q1). Martinez A, Sanz M, Pons attention Dolz Abadia, MD, PhD The primary purpose of disorder. At present our are on the study of childhood-onset (ASD) (PI: Dr Mairena, Dr Aranbarri), as well as on promoting child witnesses to domestic violence (PI: Dr \u00c1lvarez, Dr Lacasa). In recent years, our group has become consolidated through the implementation of various projects financed by public (FIS projects, MINECO) and private institutions, both national and European (European Commission), as well as through collaboration with various stable research groups of the CIBERSAM network for biomedical research on mental health, and with the G04 group of the Clinical and Provincial Hospital of Barcelona and the G01group of the Gregorio Mara\u00f1\u00f3n Hospital in Madrid. Of special note is the recent award (2021) of the FIS grant \"Multi-centre longitudinal study of markers for prediction of transition to psychosis of children and development of the TEA-CARE programme in collaboration with the Mas Casadevall Autism Foundation and financed by La Caixa Foundation, addressed to implementing a clinical programme of autism care based on research and to the education of children Paredes, Villar Cabeza, Laia Moll\u00e0 Cus\u00ed, Esther Via Virgili, Neus Elias Carbonell, Jos\u00e9 \u00c1ngel Alda D\u00edez, Mar Alvarez Segura, Ester Camprodon Rosanas, Maria Diez Juan, Fernando Lacasa Saludes, Ma \u00c1ngeles Mairena Garc\u00eda de la Torre, Josep Llu\u00eds Matal\u00ed Costa, Daniel Mu\u00f1oz Samons,, Marta Pardo Gallego, Isabel Rueda Barcena, Bernardo S\u00e1nchez Fern\u00e1ndez, Eduardo Serrano Troncoso, RESEARCHER Carolina Morales Guerrero, Berta Sanfeliu Salv\u00e0, Anna Mart\u00ednez Garc\u00eda, Federica Lombardini, Sara Parrilla Carrasco, Ingrid Tortad\u00e8s Arum\u00ed, Marina Fabrega Ribera, Carlota Saumell Andreu, Andrea SELECTED PROJECTS Impacte de l'estressor ambiental CO VID19 Ret orno Fundaci\u00f3n Alicia Koplowitz_Alba Vilaplana. (Beca Retorno_Alba Vilaplana). Fundaci\u00f3n Alicia Koplowitz. 2020-2021. IP: Montserrat Dolz Abadia. Beca Ret orno Fundaci\u00f3n Alicia Andreu. (Beca Fundaci\u00f3n Alicia Koplowitz. 2020-2021. IP: Montserrat Dolz Abadia. Efect os del tratamiento farmacol\u00f3gico en pacientes con Trastorno por D\u00e9ficit de Atenci\u00f3n y Hiperactividad (TDAH). (Ayudas Investigaci\u00f3n 2019). Banc de Sabadell, S.A. 2020-2021. IP: Miriam Sanabra Gonzalez. Disrupci\u00f3n de los ritmos cir cadianos en poblaci\u00f3n infantil con Trastornos del Neurodesarrollo (TDAH y TEA) y su impacto sobre la salud y calidad de vida. (PI19/00113). Instituto de Salud Carlos III (ISCIII). 2020-2022. STUDIES Ensayo controlado con placebo en sujet os con alto riesgo para la psicosis comparado con \u00e1cidos grasos omega-3 en Europa. PURPOSE / ABR54654. University Medical Study to Evaluate the Efficacy and Safety of 3 Fixed Doses (28 mg, 56 mg and 84 mg) of Intranasal 49 INSTITUT DE RECERCA MEDICINE AND PEDIATRIC SCIENCE AREA NEUROSCIENCE Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Cilag, Montserrat Dolz f or Psychosis Working Group; Jalbrzikowski M, Hayes RA, Wood SJ, Nordholm D, Zhou JH, Fusar-Poli P et al. Association of Magnetic Measures With Psychosis Clinical Risk for JAMA Do Caregivers and Same?. Int J Mental Health Psychiatry. 2021;7(1). Serra-Blasc o Caster\u00e0s D, Carulla-Roig M al. with circadian rhythms of motor activity, sleep disturbances, and body mass index in children and adolescents: a case-control study. Global numbers 2020-2015 Institutional awards 7.1 MEDICINE AND tissue its diseases in development and critical Allergic diseases childhood and adolescence51 INSTITUT completed the preparations to begin the recruitment of patients completed, the permits of the ethical committees and of the agencies of the participating countries were obtained, the electronic communication and patient recruitment strategy was prepared, and the production and distribution of the drugs under study was completed. Likewise, we advanced in the study of adipose tissue biomarkers in newborns and babies, and in the study of their relation to body composition, which led to the publication of articles on the intestinal microbiome, as well as the changes in the concentrations of growth and differentiation factor 15 (GDF15), which controls body weight by means of a central receptor. These studies led to the publication of two more articles in Q1. We completed the longitudinal follow-up of patients and began the analysis of the circulating exosomes and of their proteome in children with low weight and normal weight for gestational age, within the framework of the ISCIII project PI18/00109. We communicated all conferences, including those the June Paediatric Endocrinology (August 2021); and the 48th Annual Meeting of Society Paediatric Diabetes 2021). MEMBERS STAFF SilvaPHD STUDENTS Cristina Garc\u00eda Beltran ASSISTANT RESEARCHER Christian Mata Miquel, Cristina Plou P\u00e9rez TECHNICIAN Rita Maria Martins de Sousa Maia Malpique RESEARCHER Gemma Carreras Badosa, Esther Lizarraga Mollinedo, Francis de L\u00f3pez Bermejo SELECTED PROJECTS SPIOMET4HEALTH_PCOS in adol escent de exosomas circulantes y de su proteoma en ni\u00f1os nacidos con bajo peso y peso adecuado para la edad gestacional: Utilidad como biomarcador de s\u00edndrome metab\u00f3lico. (PI18/00109). Instituto de Salud Carlos III (ISCIII). 2019-2023. PI: y multic \u00e9ntrico a largo plazo en una cohorte de ni\u00f1os con talla baja nacidos peque\u00f1os para su edad gestacional (PEG) que han sido tratados con Saizen\u00ae. (EMR 200098_008 in short patients born small-for-gestional-age (SGA) followed at Hospital Sant Joan de D\u00e9u: Analysis of early predictors of good response useful in clinical practice. (WI191603). Fundaci\u00f3 Privada per a la Recerca i la Doc\u00e8ncia Sant Joan de D\u00e9u - FSJD. PI: Lourdes Iba\u00f1ez Toda. Identification of cir short children born small for gestational age: with pre- PUBLICATIONS de Zegher F, D\u00edaz M, Villarro ya J, Cairo M, L\u00f3pez A, Villarroya F et al. The relative deficit of GDF15 in adolescent girls with PCOS can be changed into Sci IF: 4,379. (Q1). D\u00edaz M, Blasco A, Villarr oya J, L\u00f3pez A, de Zegher F, Villarroya C, Malpique R, Carbonett o B, Gonz\u00e1lez P, Henares D, Brotons P et al. Gut microbiota in adolescent Su\u00f1ol Lerin Mart\u00ednez, PhD Our research focuses on gaining a better understanding of the molecular mechanisms at play when nutrition and growth during very early stages of life affect the subsequent 52 INSTITUT DE RECERCA MEDICINE AND PEDIATRIC paradigm the Origins Of Health and Disease (DOHaD). We have brought together a involving: 1. The dev experimental models (mouse) that developing new prevention and treatment strategies. the past few years, we have applied omic techniques to help further role of these biomarkers through in vitro and in animal cell studies, better understanding of the possible implication in the diseases and new nutritional-therapeutic associated metabolic disorders. MEMBERS STAFF RESEARCHER Serafin Murillo Llobet Garces, Ruben D\u00edaz Naderi, Marta Ramon Catalina Parra Vargas PHD STUDENTS Marta Mourin Fern\u00e1ndez, Ximena Molina Jos\u00e9 Carlos Jim\u00e9nez Chillar\u00f3n. Modulaci\u00f3n de la dieta dur ante las primeras etapas de la vida como estrategia de prevenci\u00f3n de la obesidad infantil. (PDC2021-121816- 100). Ministerio de Econom\u00eda Y Competitividad (MINECO). 2021- 2023. IP: Carles Lerin Martinez. Marat\u00f3 TV3. 2021- 2023. IP: Carles Lerin Martinez. El microbioma int estinal como diana terap\u00e9utica en el s\u00edndrome de Prader-Willi: efectos metab\u00f3licos y en el comportamiento de los pacientes. (PI20/00301). Instituto de Salud Carlos III (ISCIII). microbioma t erap\u00e9utica en el s\u00edndrome de Prader-Willi: efectos metab\u00f3licos y en el comportamiento de los pacientes. (PI20/00301). Instituto de Salud Carlos III (ISCIII). IP: Marta Ramon Krauel. Suplement aci\u00f3n con beta\u00edna de la dieta materna durante la lactancia como estrategia de prevenci\u00f3n de obesidad infantil. (SAF2017- 88005-R). Ministerio de Econom\u00eda Y Competitividad (MINECO). IP: Carles Lerin Martinez. SELECTED PUBLICATIONS Ribas F, Parr a M, Ramon M, D\u00edaz R, Lerin C, Cambras 2021;13(10):3579. IF:5,717. (Q1). Ribas F, Rib\u00f3 S, Parr a M, Fern\u00e1ndez A, Cebri\u00e0 J, Guardiola M et al. Neonatal 2021;45:101162. IF:7,422. (Q1). Rib\u00f3 S, S\u00e1nchez D, Mart\u00ednez L, Garc\u00eda I, Ramon M, T ondo M et al. Villarroya Gombau, In 2021, our team continued its basic and translational research on the control mechanisms of adiposity and their changes identified new adipokines and cardiokines which are predominantly produced by brown adipose tissue and heart and new control factors of adipose and cardiac plasticity in response to hormonal stimuli. In the translational field, we analysed the activity of the brown adipose tissue and the variations in the levels of new metabolic biomarkers in pathophysiological well Gavald\u00e0 Navarro, Joan Villarroya Marta Giralt Oms, Roser Iglesias Coll, Teresa Mampel Astals, Anna Planavila Porta POSTDOC ASSOCIATED RESEARCHERS Marion Peyrou, Tania Quesada L\u00f3pez, Montserrat Cair\u00f3 Calzada, Rub\u00e9n Cereijo T\u00e9llez PHD STUDENTS Laura Campderr\u00f3s Traver, Gemma Ferrer Curriu, Samantha Mor\u00f3n Ros, Celia Helena Rup\u00e9rez Gonzalo TECHNICIAN Mercedes Morales Rueda, Gemma Moreno Besora, Albert Per\u00f2 Garcia SELECTED PROJECTS ACBP, \u00bfuna nueva cardiomioquina par a la detecci\u00f3n y tratamiento de la enfermedad card\u00edaca?. Sociedad Espa\u00f1ola de Cardiolog\u00eda. Becas de ayuda para proyectos de Investigaci\u00f3n B\u00e1sica o Traslacional 53 INSTITUT DE RECERCA MEDICINE AND PEDIATRIC SCIENCE AREA ADAPTIVE RESPONSE, METABOLISM AND IMMUNOBIOLOGY en Salud Cardiovascular de la Sociedad Espa\u00f1ola de Cardiolog\u00eda y Fundaci\u00f3n Espa\u00f1ola del Coraz\u00f3n. 2021-2022. PI: Ana Planavila Porta. Descifrando el papel endocrino del t ejido adiposo marr\u00f3n: nuevos actores, nuevas funciones (PID2020-114112RB-I00). Ministerio de Ciencia e Innovaci\u00f3n (MICINN). Convocat\u00f2ria d'ajuts del Programa Estatal d'Investigaci\u00f3, Desenvolupament Estudios pr ecl\u00ednicos para determinar las alteraciones en el balance energ\u00e9tico y/o la funci\u00f3n adipocitaria subyacentes al incremento de peso corporal en personas que viven con VIH tratadas con INsTI y/o TAF (PI20/00106). Ministerio de Ciencia, Innovaci\u00f3n y Universidades. Ajuts de l'Acci\u00f3 Estrat\u00e8gica en Salut: Subprograma de projectes salut (PI). 2020-2023. PI: Marta Giralt Oms. Neonatology research group Martin Iriondo Sanz, MD, PhD Our group has two main research lines: nutrition and prematurity, on the one hand, and the critical patient, on the other. In our nutrition and prematurity line, we have helped to demonstrate, within the framework of a European multi-centre study, the utility of the continuous monitoring of the blood glucose level in real time in premature patients under intensive care. We continued investigating the factors present in human milk that may have an impact on the development of very premature newborns (born sooner than the 32nd week of special attention to microbiota and to the hormonal also studied the long-term our our of very premature newborns in the prepubertal period, focusing on the evolution of their growth, metabolism and neurodevelopment. With respect to the critical patient, we continue to research brain injury, especially in the patients affected by congenital non-invasive allowed us to collaborate on a European project for the development of a new integrated neuromonitoring device (TinyBrains). The use of a new optical technology will help us to determine non-invasively oxygen consumption at all times, haemodynamics-dependent changes in cerebral blood flow, and changes in brain electrical activity during the most vulnerable periods or at moments of greatest risk, such as during surgery or in the immediate postoperative period. Along this same line, our studies with of brain injury and oxidative for clinical assessment strategies for the period of foetal life or at the patient's bedside, providing us with instruments that will help us to detect patients at risk in order to be able to implement neuroprotective strategies. All this is being done with a translational approach, expanding our knowledge through experimental animal models. MEMBERS STAFF RESEARCHER Cristina Carrasco Carrasco, Isabel Iglesias Platas, Ana Morillo Palomo POSTDOC ASSOCIATED RESEARCHERS Esponera, Jordi Clotet Caba, Ruth Del Rio Florentino, Beatriz Del Rey Hurtado De Mendoza, Montserrat Izquierdo Renau, Alba Rivas Piorno ASSISTANT RESEARCHER Ines Fernanda Medina Rivera COLLABORATOR RESEARCHER Mar\u00eda Dolores Salvia Roiges, Mattia Bosio, Marta Thi\u00f3 Lluch, Cristina Borr\u00e0s Novell, Ana Herranz Barbero SELECTED PROJECTS Validaci\u00f3n prospectiva mediante un es tudio multic\u00e9ntrico estatal (REDSAMID) de modelos predictivos de mortalidad neonatal en prematuros. (PI20/00295). Instituto de Salud Carlos III (ISCIII). 2021-2023. IP: Martin Iriondo Sanz. Consecuencias en la infancia del f allo perinatal de crecimiento en Reci\u00e9n Nacidos Muy Prematuros: estudio cl\u00ednico y metabol\u00f3mico. (PI20/00294). Instituto de Salud Carlos (ISCIII). 2021-2023. IP: Isabel Iglesias Platas. TinyBrains_Bio-phot onic imaging of the infant brain, the missing link between the cellular brain damage and the del Alopurinol en pacient es con encefalopat\u00eda hip\u00f3xico-isqu\u00e9mica tratados con hipotermia. ALBINO ensayo cl\u00ednico multic\u00e9ntrico, aleatorizado, ciego, controlado con placebo. (H2020- PHC-18-2015-667224). Instituto de investigaci\u00f3n Sanitaria Hospital La Fe. 2017-. Marta Camprubi Camprubi. Evaluation of preterm infant. (REACT University of Cambridge. 2017-. IP: Isabel Iglesias Platas. SELECTED PUBLICATIONS Aldecoa V, Velilla M, Teresa M, Bal cells C, Herranz A, Sin M, Iriondo M, Salvia D. Lung Ultrasound in Bronchopulmonary FM, Pertierra A, Martinez JM al. L, Guy C, Igl esias I, van MM, Bond S et al. Real-time Health. 2021;5(4):265-273. IF:11,288. (Q1). Dur\u00e1n F ern\u00e1ndez C, Rodr\u00edguez J, 54 INSTITUT DE RECERCA MEDICINE AND PEDIATRIC SCIENCE AREA ADAPTIVE RESPONSE, METABOLISM AND IMMUNOBIOLOGY L\u00f3pez M, Hadley S, Cavia Mu\u00f1iz P et al. Effects of Hypothermia and Allopurinol on Oxidative Status Carrera, PhD The purpose of our line of research is to study new pharmacological targets for the treatment of insulin resistance and type 2 diabetes, as well as More specifically, one of our group's research lines is the study of the molecular mechanisms by which the activators of the In 2021, our research group discovered that a large part of the antidiabetic and anti-inflammatory effects of the PPAR/ the GDF15 (growth many biological processes including the not appear to require the presence of GFRAL, which is the central receptor responsible for the action of GDF15. This fact suggests the presence of other peripheral receptors of GDF15 which could be responsible for this action. Likewise, in collaboration with the Pharmaceutical Chemistry Unit of our department, we took part in a study in which nine compounds were synthesized which inhibit the soluble epoxide and stress of in an animal model of acute pancreatitis, a disorder for which there is not yet any specific pharmacological treatment. MEMBERS STAFF RESEARCHER F. Xavier ASSOCIATED RESEARCHERS Emma Barroso Fern\u00e1ndez, Marta Montori Grau, Luc\u00eda Pe\u00f1a Moreno, Javier Pizarro Delgado SELECTED PROJECTS Unveiling the role of the growth Mar\u00eda Garcia Altares. Activaci\u00f3n de PP ARb/d y HRI: explorando nuevos mecanismos compensatorios para el tratamiento de la inflamaci\u00f3n, la resistencia a la insulina y la esteatohepatitis no alcoh\u00f3lica (RTI2018-093999- B-I00). Convocat\u00f2ria d'ajuts als reptes de la Societat. Modalitat Reptes. Ministerio de Ciencia, Innovaci\u00f3n y Universidades. 2019-2022. PI: Manuel Vazquez Carrera. Diabetes cooperativa, a l'\u00e0rea de biomedicina i ci\u00e8ncies de la salut, en el marc del Programa Ingenio 2010, Programa Consolider, accions CIBER. Ministerio de Sanidad y Consumo. 2007-2022. PI: Manuel Vazquez Carrera.SELECTED PUBLICATIONS Aguilar D, Barroso E, Gum\u00e1 L, Pizarr o J, Pena L, Ruart M et E, Osuna S, Morisseau C, Loza MI et al. From the Design to the In Vivo Evaluation of Benzohomoadamantane-Derived Soluble Epoxide Hydrolase Inhibitors 2021;64(9):5429-5446. IF:7,446. D, Garc\u00eda R, Nistal JF, Vazquez M. Sirtuins: To Be or Not To Diabetic Cardiomyopathy. Trends Mol Med. (GEMDIP) Laia Alsina Manrique de Lara, MD, PhD & Jordi Ant\u00f3n L\u00f3pez, MD, PhD The group to study the pathophysiological bases of these diseases and have published several high-impact articles. Our focus has been (multisystem inflammatory PEDIATRIC AREA MEMBERS Violeta Bittermann, Juan Manuel Mosquera Angarita, Ana M\u00aa Plaza Mart\u00edn, Andrea Zacarias Crovato, Rosa Bou i Torrent, \u00c0ngela Dey\u00e0 Mart\u00ednez, STUDENTS Yiyi Luo, Joan Calzada Hern\u00e1ndez ASSISTANT RESEARCHER Lucia Rodriguez Diez, Clara Isabel Gim\u00e9nez Roca COLLABORATOR RESEARCHER Jordi Yag\u00fce Ribes, Manel Juan Otero, Juan Ignacio Gorospe SELECTED PROJECTS Characterization of the nasopharyngeal micr obiota de (ISCIII). 2021-2023. PI: Jordi Ant\u00f3n L\u00f3pez. PIVIT_Construc ci\u00f3 d'una sala d'Ajuts Universitaris i de Recerca; Departament de Salut - Generalitat de Catalunya. 2020-2022. PI: Laia Alsina Manrique de Lara. Contrat o predoctoral de formaci\u00f3n en investigaci\u00f3n en salud_Beneficiario: Yiyi Luo. (FI19/00208). Instituto de Salud Carlos III (ISCIII). 2020-2023. PI: Laia L\u00f3pez. Los nuev os criterios de PRINTO para la clasificaci\u00f3n de la artritis idiop\u00e1tica juvenil. Un proyecto basado en la evidencia cient\u00edfica para la revisi\u00f3n de los criterios de la Liga Internacional contra el Reumatismo (ILAR). (ILAR). Accountancy Departament Instituto STUDIES Estudio abierto, multic\u00e9ntrico, de dos c ohortes y un solo grupo para evaluar la eficacia, la seguridad y la tolerabilidad, la farmacocin\u00e9tica y la farmacodin\u00e1mica de emapalumab en ni\u00f1os y adultos con s\u00edndrome de activaci\u00f3n de macr\u00f3fagos (SAM) en la enfermedad de Still (incluida la artritis idiop\u00e1tica juvenil sist\u00e9mica y la enfermedad de Still del adulto) o con SAM en el lupus eritematoso sist\u00e9mico. A two-cohort, open- label, single arm, tolerability, pharmacokinetics in systemic lupus erythematous. 0501-14). Pharmaceutical Research Associates Espa\u00f1a SAU; Swedish Orphan Biovitrum AG. 2021-. PI: Jordi Ant\u00f3n L\u00f3pez. Estudio abiert o y de dosis m\u00faltiples ascendentes para evaluar la seguridad, tolerabilidad, farmacocin\u00e9tica de romosozumab en ni\u00f1os y 2021-. PI:Rosa Torrent. SELECTED PUBLICATIONS Brogan PA, Arch B, Hickey H, Ant on J, Iglesias E, Baildam E et al. Mycophenolate Mofetil Versus Faura A, Torrebadell M, Vlagea A et al. Kinetics of AP, Vlagea A, Jord\u00e1n I, Fumad\u00f3 V, Fortuny C et al. Confirmed SARS-COV-2 Infection In A Cohort Of eve A, Anton J, Pino RM, S\u00e1nchez J, Fumad\u00f3 V, Fortuny C et al. Similarities and Almagro, MD, PhD We were acknowledged as an emerging group in 2009, as a consolidated group in 2014, and as a consolidated group with AGAUR financing (SGR00742) in 2017. Consortium for Networked Biological Research on Epidemiology and Public Health (CIBERESP) since 2016. Our group is focused on the study of the clinical, molecular and epidemiological aspects of the principal diagnostic innovation of infectious the study of the human microbiome. The cumulative impact factor of our group has been 1176.34 over the last 5 years and it is following an upward trend. Ours is a multidisciplinary team formed and management. are directed by doctors who combine their research activity with university teaching. Two of them are full professors (Dr Fortuny and Dr 56 INSTITUT DE RECERCA MEDICINE AND PEDIATRIC SCIENCE AREA Jord\u00e1n, Dr Noguera- Juli\u00e1n and Dr Garc\u00eda-Garc\u00eda), one is an adjunct lecturer (Dr Launes) and one is a contracted doctor (Dr Brotons). In 2021, we consolidated our human microbiome line, as is shown by our five publications on this subject. Also of note are our studies on the impact of the COVID-19 pandemic on the paediatric population, which carried the collaboration of numerous donors who supported our research. We published articles Maria Goretti L\u00f3pez Ramos, Antoni Noguera Juli\u00e1n, Pedro Brotons de los Reyes, Victoria Fumad\u00f3, Juan Jos\u00e9 Garc\u00eda Garc\u00eda, Cristian Launes Monta\u00f1a, Silvia Sim\u00f3 Nebot POSTDOC ASSOCIATED RESEARCHERS Muntsa Rocafort PHD STUDENTS Mar\u00eda Rios Barn\u00e9s, Ferran Bossacoma Busquets, Garc\u00eda, Sanchis Badenes, Alba Redin Alonso, Susana Hern\u00e1ndez Bou TECHNICIAN Carles Amaresh P\u00e9rez Arg\u00fcello, Jesica Saucedo Verdes COLLABORATOR RESEARCHER Quique Bassat, Emilia S\u00e1nchez Ruiz SELECTED PROJECTS Tecnolog\u00edas NGS para la Vigilancia Epidemiol \u00f3gica Molecular de S. pneumoniae y para determinar su invasividad. Quo vadis y Quo invades pneumococcus?. (PI19/00104). Instituto de Salud Carlos III (ISCIII). 2020-2022. Mu\u00f1oz Almagro. Estudio CRIB (Cribado de cit omegalovirus cong\u00e9nito en reci\u00e9n nacidos sanos e ingresados - Barcelona). (PI19/00095). Instituto de Salud Carlos III (ISCIII). 2020-2022. IP: Antoni Noguera Juli\u00e1n. Contract infrastructure and performing vaccine COVID-19 orma Kids Corona. 2020-2022. IP: Garc\u00eda. SELECTED CLINICAL TRIALS STUDIES Estudio de fase II, sin enmasc aramiento, no comparativo y multic\u00e9ntrico para evaluar la seguridad, la tolerabilidad, la eficacia y la farmacocin\u00e9tica del sulfato de isavuconazonio en el tratamiento de la aspergilosis invasiva (AI) o la mucormicosis invasiva (MI) (9766-CL-0107). Astellas Fortuny Guasch. Estudio de f ase 3, multic\u00e9ntrico, alatorizado, con enmascaramiento parcial y controldo con palivizumab para evaluar la seguridad, la eficacia y la farmacocin\u00e9tica de MK-1654 en lactantes y ni\u00f1os con unriesgo elevado de enfermedad VRS. Randomized, Partially Pharmacokinetics of MK-1654 in Infants Children at Increased Severe RSV Disease. IP: Cl\u00e0udia Fortuny Guasch. Estudio f ase III, aleatorizado, doble ciego, controlado con placebo y multic\u00e9ntrico para demostrar la eficacia de una dosis \u00fanica de la vacuna materna no adyuvada frente al Virus Respiratorio Sincitial (VRS), administrada por v\u00eda IM a gestantes de 18 a 49 a\u00f1os de edad, para la prevenci\u00f3n de la Enfermedad v\u00edas respiratorias Bajas (EVRB) asociada al VRS en sus hijos hasta los 6 meses de edad. (212171 (RSV MAT- 009)). Glaxosmithkline, S.A. 2021-. IP: Victoria Fumad\u00f3. Estudio de inmunogenia y seguridad de una v acuna conjugada antimeningoc\u00f3cica tetravalente con respecto a Nimenrix\u00ae, y cuando se administra sola o de manera concomitante con las vacunas 9vHPV-IPV en adolescentes sanos. (MEQ00071). Sanofi-Aventis S.A. 2021-. IP: Antoni Noguera Juli\u00e1n. SELECTED PUBLICATIONS Brotons P, Launes C, Buetas E, F umad\u00f3 V, Henares D, Fern\u00e1ndez de Sevilla M et al. Susceptibility to Severe Acute Respiratory A Seroprevalence Study of Family Households in the Barcelona Metropolitan Region, Spain. Clin Infect Dis. 2021;72(12):1-8. IF:9,079. (Q1). Est eve A, Anton J, Pino RM, S\u00e1nchez J, Fumad\u00f3 V, Fortuny C et al. Similarities and Henares D, Br otons P, Fern\u00e1ndez de Sevilla M, Fern\u00e1ndez A, Hern\u00e1ndez S, P\u00e9rez A et al. Differential nasopharyngeal microbiota composition IF:5,237. (Q1). Redin A, Ciruela P, Fern\u00e1ndez de Se villa M, Gomez F, Gonzalez S, Benitez MA et al. Serotypes and Clonal Composition Streptococcus pneumoniae Isolates Causing IPD in Children and Adults in Catalonia before 2013 to 2015 and after 2017 immune system. studies of our group showed 57 RECERCA AND PEDIATRIC we have provided new insights used by microbiota to orchestrate host immune regulation. with the derived immune responses. To our knowledge, this is the first study showing the influence of microbiota In the context of contribution study of biological activities of nanoparticles for drug delivery, we have collaborated with groups of the Nanobiotechnology Research Institute-UB. In particular, we have shown that thymol-loaded nanoparticles are an efficient alternative for the treatment of acne infection liposomes as a drug delivery system for the treatment of dry eye disease. MEMBERS STAFF RESEARCHER Rosa Gim\u00e9nez Claudia, Josefa Badia Palacin SELECTED PROJECTS Evaluaci\u00f3n de nuevas actividades de v es\u00edculas secretadas por probioticos y microbiota intestinal y su potencial aplicaci\u00f3n como postbioticos en salud humana. (PID2019-107327RB-I00). Ministerio de Ciencia, Innovaci\u00f3n y Universidades. Convocat\u00f2ria d'ajuts del Programa Estatal d'Investigaci\u00f3, Desenvolupament i IF:25,841. (Q1). Diaz N, Corder Baldoma L. by Host-Released J. Mol. Sci. 2021;22(4):2213. IF:5,923. (Q1). Foll e C, Marqu\u00e9s AM, Jorge G, Espina M, S\u00e1nchez E, Badia J et al. Thymol-loaded PLGA nanoparticles: IF:10,435. (Q1). L\u00f3pez A, Jorge G, Cano A, Espina M, Badia J, Baldoma L et al. De velopment of Lactoferrin-Loaded Liposomes for the Management of Pharmaceutics. 2021;13(10):1698. IF:6,321. Roig, MD, PhD We continued to study the influence of abusive substances and of the materno-foetal environment on foetal and newborn health. We completed the recruitment of the Barcelona Life Study Cohort (BISC), which comprises 1,100 mother- child pairs in the Barcelona area, who are well phenotyped for environmental exposure. With this cohort, we will be able to continue conducting research along our line. Our areas of interest are the study of the influence of lifestyle and exposure to environmental contaminants on 58 ADAPTIVE also extended our studies to new frequency-following response (FFR). Another aspect of the work that we have carried out is the study of how the environment affects the placental function and foetal growth, and it may also be noted that we have increased our experimental knowledge about alcohol consumption during pregnancy. RESEARCHER Eduardo Gonz\u00e1lez Bosquet, N\u00faria Lorente Colom\u00e9, Rosalia Pascal Capdevila, Silvia Irena Ferrero Mart\u00ednez, Joan Sabri\u00e0 Bach POSTDOC ASSOCIATED RESEARCHERS Edurne Mazarico Gallego, Miriam P\u00e9rez Cruz PHD Aurrocoechea, Diana Lucia Lip Sosa ASSISTANT Nat\u00e0lia Gorina Careta, Patricia Ferrer Aguilar, Laura Mall\u00e9n Perez, Marc Josep Cahuana Bartra, Estela Toledano TECHNICIAN \u00c0gueda Garc\u00eda Meseguer SELECTED PROJECTS Impacto de un programa de int ervenci\u00f3n prenatal estructurado, de disminuci\u00f3n de consumo de alcohol, en los resultados perinatales y de neurodesarrollo. (PI20/00490). Instituto de Salud Carlos III (ISCIII). 2021-2023. PI: Maria Dolores G\u00f3mez Roig. Respuest a de seguimiento de frecuencia (RSD) como biomarcador de desarrollo neurocognitivo en reci\u00e9n nacidos con exposici\u00f3n prenatal al alcohol. Hospital Sant Joan de D\u00e9u - Esplugues HSJD. 2020-2023. PI: Maria Dolores G\u00f3mez Roig. ATHLETE_Adv ancing function, space, physical activity, and (CR-83590201). Health del restringido precoz con de bajo peso molecular: Ensayo Cl\u00ednico Randomizado (TRACIP). (FSJD-TRACIP-2017). Fundaci\u00f3 Privada per a la Recerca i la Doc\u00e8ncia Sant Joan de D\u00e9u - FSJD. 2017-. PI: Edurne Mazarico Gallego. Tr atamiento del cir precoz con heparina de bajo peso molecular (TRACIP): ensayo cl\u00ednico randomizado. (PI16/00151). Instituto de Salud Carlos III (ISCIII). 2017-2021. PI: Edurne Mazarico Gallego. SELECTED PUBLICATIONS Almeida L, Andreu V, Ar as R, Garc\u00eda \u00d3, Mart\u00ednez L, G\u00f3mez MD. Epigallocatechin Gallate Ameliorates the Effects of Prenatal Alcohol Exposure in a Fetal Alcohol Spectrum Disorder-Like Mouse Model. Int. J. Mol. Sci. 2021;22(2):715. IF:5,923. (Q1). Arenillas S, Cos ta J, Ribas C. Neural encoding Llurba A, Peguero A, Martinez J et al. experience protocol-based of small-for-gestational-age fetuses: (Q1). diseases in MD, PhD & Georgia Sarquella Brugada, MD, PhD MEMBERS STAFF RESEARCHER Esther Aurensanz Clemente, Jose Carlos Cruzalegui G\u00f3mez, Esther Carro Fernandez, Sergio C\u00e9sar Diaz, Isaac Moll Adrian PHD STUDENTS Oscar Recasens Lopez, Maria Lucia Rossi, Estefan\u00eda Mart\u00ednez Barrios ASSISTANT RESEARCHER Alba Rivas Piorno, D\u00e9bora Ca\u00f1izo V\u00e1zquez, Joana Victoria Fiol Ramis TECHNICIAN Bosco Alejandro term outcome for data integration from fetus to childhood. (202016-31). Fundaci\u00f3 La Marat\u00f3 de TV3. 2021-2024. IP: Joan S\u00e1nchez de Toledo. Antioxidant es y neuroprotecci\u00f3n en un modelo animal pedi\u00e1trico de circulaci\u00f3n extracorporea y parada circulatoria: Nuevos horizontes terap\u00e9uticos. (PI20/00298). Instituto de Salud Carlos III (ISCIII). 2021- 2023. IP: Joan S\u00e1nchez de Toledo. AICCELERATE_AI Ac \u00e2\u20ac\" A Hospital Care Pathway Engine. IP: Joan S\u00e1nchez de Toledo. TinyBrains_Bio-phot onic imaging of the infant brain, the missing link between the cellular brain damage and the neurovascular unit during acute illness. (101017113). European Commission. 2021-2024. IP : Joan S\u00e1nchez de Toledo. ECG neonatal sis tem\u00e1tico para la 59 INSTITUT DE RECERCA MEDICINE AND PEDIATRIC SCIENCE AREA ADAPTIVE RESPONSE, METABOLISM AND IMMUNOBIOLOGY detecci\u00f3n precoz de enfermedades cardiacas relacionadas con la muerte s\u00fabita del lactante. Sociedad e ciego, controlado con placebo, de grupos paralelos, basado en acontecimientos y con dise\u00f1o secuencial por grupos con un periodo de ampliaci\u00f3n abierto para evaluar la eficacia y seguridad de selexipag como tratamiento complementario al tratamiento de referencia en ni\u00f1os de \u00e2\u00a52 a <18 a\u00f1os con hipertensi\u00f3n Period to Assess the Efficacy and Safety of Selexipag as Add-On Treatment to Standard of Care in Children Aged \u00e2\u00a52 to <18 years with - Cilag, 2020-. IP: Joan S\u00e1nchez de Toledo. Estudio multic \u00e9ntrico para evaluar la seguridad y tolerabilidad a largo plazo de un tratamiento en abierto con sacubitrilo/ valsart\u00e1n en pacientes pedi\u00e1tricos con insuficiencia cardiaca debida a disfunci\u00f3n sist\u00f3lica de ventr\u00edculo izquierdo sist\u00e9mico, que han completado el estudio CLCZ696B2319. (CLCZ696B2319E1 - Ext.). Novartis Farmac\u00e9utica, S.A. 2020-. IP: Joan S\u00e1nchez de Toledo. Estudio multic \u00e9ntrico, abierto, para evaluar la seguridad, tolerabilidad, farmacocin\u00e9tica y farmacodin\u00e1mica de LCZ696, seguido de un estudio de 52 semanas, aleatorizado, doble ciego, paralelo controlado con f\u00e1rmaco activo para evaluar la eficacia y seguridad de LCZ696 comparado con enalapril en pacientes pedi\u00e1tricos con edades desde 1 mes hasta < 18 a\u00f1os, con insuficiencia cardiaca debida a disfunci\u00f3n sist\u00f3lica del ventr\u00edculo izquierdo sist\u00e9mico. (CLCZ696B2319). Novartis Farmac\u00e9utica, S.A. 2019-. IP: Joan S\u00e1nchez de Toledo.SELECTED PUBLICATIONS Esteve A, Anton J, Pino RM, S\u00e1nchez J, F umad\u00f3 V, Fortuny C et al. Similarities and G, F ernandez A, Cesar S, Arbelo E, Jord\u00e0 P, Garc\u00eda A et al. Pediatric Caused (Q1). Sarquella G, Lor ena A, Zambrano MD, Fern\u00e1ndez A, Sailer S, Cesar S et al. Early Identification of Prolonged QT Interval for Front 2021;9:704580-704580. (Q1). verde I, Singh Y, Sanchez J, Theocharis P, Chikermane A, Di S et al. Acute Cardiovascular Manifestations in 286 Children With Multisystem Inflammatory Immune and Jos\u00e9 Cambra Lasaosa, MD, PhD Notable aspects of 2021 included our research on the of illness caused by adults, considering the number patients over age 18 years hospitalised in our intensive care unit during the in depth and produced several publications. Our research, which was led by Dr Iolanda Jordan, was conducted with a multidisciplinary approach, involving various services of our hospital. Our scientific output was maintained with several publications along our two priority research lines: the field inflammatory response and Also critical patients\". The thesis was directed by Iolanda Jordan and Francisco Jos\u00e9 Cambra. University of Barcelona (UB). Grade: Excellent Cum Laude. MEMBERS STAFF RESEARCHER Ribalta, Carmina Guitart Pardellans, M\u00f3nica Esteban Torne, M\u00f3nica Girona Alarc\u00f3n ASSISTANT RESEARCHER Jorgelina Lopez Zabala, Vanessa Andrino Estrecha, Nuria Mill\u00e1n Garc\u00eda del Real, Elena Fres\u00e1n Ruiz, Sergio Benito Fern\u00e1ndez, Lluisa Hernandez Platero, Carme Alejandre Galobardes, Patricia Corniero Alonso, Aida Felipe Villalobos, Susana Segura Matute, David Vila P\u00e9rez, Sergi Huerta Calpe, Ricardo Suarez Ramirez COLLABORATOR RESEARCHER Montserrat eriana de la nasofaringe en el desarrollo de neumon\u00eda asociada a ventilaci\u00f3n mec\u00e1nica en la unidad de cuidados intensivos pedi\u00e1tricos. Estudio MiNoReP. (PI19/00106). Instituto de Salud Carlos III (ISCIII). 2020-2022. IP:Iolanda Jord\u00e1n Garc\u00eda. Val oraci\u00f3n del efecto neuroprotector de la dexmedetomidina en el modelo animal pedi\u00e1trico de circulaci\u00f3n extracorporea y parada circulatoria. Sociedad y Fundaci\u00f3n Espa\u00f1ola de Cuidados Intensivos Pedi\u00e1tricos (SECIP). 2018-2022. IP: Sergio Benito Fern\u00e1ndez. Estudio de seguridad de un dispositiv o de presi\u00f3n positiva no mec\u00e1nico en pacientes con insuficiencia respiratoria 60 INSTITUT DE RECERCA MEDICINE AND PEDIATRIC SCIENCE AREA ADAPTIVE RESPONSE, METABOLISM AND hipox\u00e9mica secundaria a neumon\u00eda por SARS COV 2. (CPAP). Fundaci\u00f3 Privada per a la Recerca i la Doc\u00e8ncia Sant Joan de D\u00e9u - aleatorizado con control activ o para comparar la eficacia y la seguridad de isoflurano inhalado administrado por el AnaConDa-S (dispositivo de conservaci\u00f3n de anest\u00e9sico) con el midazolam intravenoso para la sedaci\u00f3n en pacientes pedi\u00e1tricos con ventilaci\u00f3n mec\u00e1nica de entre 3 y 17 a\u00f1os (menos de 18 a\u00f1os). A Randomised Active-controlled Study to Compare Efficacy and LINK Medical Research; Sedana Medical AB. 2021IP:Monica Girona Alarcon. Estudio abiert o, de un solo brazo para evaluar la farmaconcin\u00e9tica, seguridad y tolerabilidad, y para explorar los resultados cl\u00ednicos del tratamiento con dosis \u00fanica o m\u00faltiple de zanamivir IV en neonatos e infantes menores de 6 meses con infecci\u00f3n por gripe confirmada complicada. An open label, single arm study to evaluate the pharmacokinetics, safety and tolerability of intravenous hospitalised and or suspected influenza infection. (200925). Glaxosmithkline, S.A. Iolanda Jord\u00e1n Garc\u00eda. SELECTED PUBLICATIONS Alejandre C, Guitart C, Balaguer M, T orr\u00fas I, Bobillo S, Cambra F J et al. Use of procalcitonin and C-reactive protein in the diagnosis of (Q1). Bobillo S, Balaguer M, Jor d\u00e1n I, Batista A, Ramon M, Otero O et al. Delivery room ultrasound study to assess heart rate Doba\u00f1o C, Alonso S, F ern\u00e1ndez de Sevilla M, Vidal M, Jim\u00e9nez A, Pons G et al. Antibody conversion rates to SARS-CoV-2 in saliva from children attending in Barcelona, Spain. BMC Med. 2021;19(1):309. IF:8,775. (Q1). Esquerda M, P alau F, Lorenzo- Izquierdo D, Cambra F J, Bofarull M, Cusi V et al. Ethical questions MD, PhD MEMBERS STAFF RESEARCHER Rosa Feijoo, Jaime Lozano Machinena Spera PHD STUDENTS Olga Dominguez S\u00e1nchez de la alergenicidad de dif erentes prote\u00efnes en la alergia alimentaria a pescado en poblaci\u00f3n pedi\u00e0trica. Sociedad Espa\u00f1ola de Inmunolog\u00eda Cl\u00ednica, Alergia y Asma Pedi\u00e1trica. 2021-2022. IP: Olga Dominguez S\u00e1nchez. Genetics of Food Estudio de 52 semanas, al eatorizado, doble ciego, controlado con placebo, de grupos paralelos, multic\u00e9ntrico sobre la eficacia y seguridad de la terapia adyuvante de GSK3511294 en participantes adultos y adolescentes con asma grave no controlada con un fenotipo eosinof\u00edlico. A 52-week, randomised, double-blind, placebo-controlled, parallel-group, in adult Spain SL. 2021-. IP: Jaime Lozano Blasco. Estudio de 52 semanas de dur aci\u00f3n, aleatorizado, doble ciego, con doble simulaci\u00f3n, de grupos paralelos, multic\u00e9ntrico, de no inferioridad, para evaluar la tasa de exacerbaci\u00f3n, las mediciones adicionales de control del asma y la seguridad en participantes adultos y adolescentes con asma grave con fenotipo eosinof\u00edlico tratados con GSK3511294 en comparaci\u00f3n con additional safety adolescent Lozano Blasco. SELECTED PUBLICATIONS Escarrer M, Julia JC, Quevedo S, Priet o Del A, M\u00f3nica Paola Sandoval R, Quesada F et al. Cambios en la epidemiolog\u00eda y en la pr\u00e1ctica cl\u00ednica de la alergia mediada por IgE en pediatr\u00eda. An. Chivato T, Del SR numbers 2020-2015 Institutional awards 7.1 MEDICINE AND PEDIATRIC H\u00e9ctor Salvador Hern\u00e1ndez POSTDOC Garc\u00eda L\u00f3pez, Gomez Gonzalez PHD Al\u00edcia Garrido Garcia ASSISTANT RESEARCHER Alba Parra TECHNICIAN Sonia Paco Mercader, Isadora Lemos Das Neves SELECTED PROJECTS Desarrollo de clasificadores epigen\u00e9tic os para el C\u00e1ncer Pedi\u00e1trico (ECPC). 2020-2023. IP: Cinzia Emilia Lavarino. M\u00e9todo par a la clasificaci\u00f3n en subgrupos moleculares de pacientes con Meduloblastoma. (PI17/00353). Instituto de Salud de Fase I/II, Abierto y de un sol o brazo para Evaluar la Farmacocin\u00e9tica, Seguridad/ Tolerabilidad y Eficacia de la Formulaci\u00f3n Granulada de Selumetinib en ni\u00f1os de 1 a < 7 A\u00f1os con Neurofibromas Plexiformes (NP) Sintom\u00e1ticos e Inoperables Astrazeneca Farmaceutica Spain, S.A. 2021-. IP: H\u00e9ctor Salvador Hern\u00e1ndez. Ensayo f ase I, de un solo brazo, secuencial, para evaluar el efecto de los alimentos sobre la seguridad y farmacocin\u00e9tica de selumetinib despu\u00e9s de dosis m\u00faltiples en ni\u00f1os adolescentes con neurofibromas plexiformes (NP) asociados a neurofibromatosis tipo 1 (NF1). I, Single-Arm, Sequential Study to Evaluate the Effect of Food on the Gastrointestinal Toxicity and Pharmacokinetics of Selumetinib after Multiple Doses in (NF1) IP: H\u00e9ctor Salvador Hern\u00e1ndez. SELECTED PUBLICATIONS Khan S, Solano P, Suwal T, Lu M, Al S, Ho B et al. Clinical phenotypes study. Lancet Child Adolesc Health. 2021;5(11):800-813. IF:11,288. (Q1). Petit M, Guasp M, Armangue T, Lav arino C, Morales A, Saiz A et al. Absence M, Su\u00e1rez L, Guiu M, Gros L, M\u00e9ndez O et al. Loss of Enhances Bone M, Schrimpf D, Stichel D et al. Recurrent fusions 2021, while we were still immersed in the pandemic, which has fortunately not adversely affected children and juveniles, our Cancer Group carried on with its mission of expanding our knowledge of this disease, which is responsible for the greatest mortality in the child population of the advanced countries. In the scientific sphere, mention should be made of the publications of the neuroblastoma immunotherapy team directed by Dr Jaume Mora, which has become consolidated as an international reference group in the treatment of high-risk neuroblastoma. The information collected in the provided of our centre, allowed the FDA to approve naxitamab for the treatment of relapsed/refractory neuroblastoma in bone on 20 November 2020. MEMBERS Martin Serrano, Irene Cuervas Oliveras, Alejandro Manzanares Quintela, Estela Prada Varela, Sara P\u00e9rez Jaume TECHNICIAN Soraya Morales Moreno, \u00d3scar Mu\u00f1oz Aznar, Noelia Salvador Marcos COLLABORATOR RESEARCHER Maria Inmaculada Mu\u00f1oz osarcoma. PAEDIATRIC CANCER Roche Diagnostics Influencia del cont exto epigen\u00e9tico en la edad como factor pron\u00f3stico en Ewing Sarcoma. (PI20/00179). Instituto de Salud fase II de inmuno-onc olog\u00eda de precisi\u00f3n con indicaci\u00f3n tumor agn\u00f3stica Graupera. ov adults with and Garraus ase 1, multic\u00e9ntrico, abierto, con intesificaci\u00f3n de dosis y expansi\u00f3n de cohorte con Niraparib y Dostarlimab en pacientes pedi\u00e1tricos con tumores s\u00f3lidos recurrentes o refractarios. A phase 1, multicentre, open-label, dose- escalation recurrent or tumours. and Development Ltd. 2021IP: Jaume Mora Graupera. SELECTED PUBLICATIONS Mora J, Casta\u00f1eda A, Colombo MC, Gor ostegui M, Fernando M, Ma\u00f1e S et al. Clinical Gorostegui M, Santa V, Garraus M, Mu\u00f1oz JP et al. Naxitamab combined G, P\u00e9rez S, Resa C, Vil\u00e0 M, Monterrubio C et J, Hajji N, S\u00e1nchez S, Figuerola E, de Pablos RM, Espinosa AM et al. Selective inhibition of HDAC6 regulates Cuadrado Vilanova, Helena Castillo Ecija ASSISTANT RESEARCHER Francisco Javier Vicario la Torre, V\u00edctor Burgue\u00f1o Sandoval, Leire Balaguer Lluna, Merc\u00e8 RESEARCHERS Guillermo Chantada, Ofelia Madrid SELECTED PROJECTS Desenvolupament precl\u00ednic del f Angel Montero Carcaboso. Contrat o predoctoral de formaci\u00f3n en investigaci\u00f3n en salud_ Beneficiario: Helena Castillo. (FI19/00138). Instituto de Progr ama cl\u00ednico internacional para el diagn\u00f3stico y tratamiento de ni\u00f1os, adolescentes y adultos j\u00f3venes con ependimoma. (ET-13-002). Sociedad Espa\u00f1ola de Autologous Cells a la Recerca i la Doc\u00e8ncia Sant Joan de D\u00e9u - FSJD. 2016-- IP: Andr\u00e9s Morales La Madrid. Estudio pr ospectivo internacional en ni\u00f1os mayores de 3 a 5 a\u00f1os con meduloblastoma de riesgo est\u00e1ndar cl\u00ednico de perfil biol\u00f3gico de bajo riesgo. (SIOP - PNET 5 MB - LR). Ganiewich D, Gomez S, P\u00e9rez S, Resa C, Vil\u00e0 M, Monterrubio C et G, Y, Vedaraju Y, Faughnan L et al. Global characteristics and outcomes SARS-CoV-2 in children ers P, Henneken SC, Blume 64 INSTITUT DE RECERCA MEDICINE AND PEDIATRIC SCIENCE AREA PAEDIATRIC CANCER C, Sill M, Schrimpf D, Stichel D fusions Leukaemias and Other in 2021, despite external difficulties. We continued to work on the had been previously begun and we obtained important grants for the start-up of new projects. For example, some new projects were implemented in 2021 in relation to acute leukaemia. On the one hand, Dr Catal\u00e0 is leading the GEMMA study for the complete characterisation of the myelodysplastic funded by the Foundation La Marat\u00f3 de TV3. On the other hand, the Unoentrecienmil (One in a Hundred Thousand) Foundation financed a project to facilitate protocol. Our activity in clinical trials was very intense in all fields in 2021, and our group leads and participates in Alvarez, Isabel Badell Serra, Julia Marsal Ricoma, Ruben Berrueco Moreno, Albert Elena Esperanza Cebollada, Sandra Pont Marti, Castillo, Anna Estella Aguado, Merc\u00e9 Richarte Frnaqu\u00e9s SELECTED PROJECTS New Marat\u00f3 TV3. 2021-2024. IP: Albert Catal\u00e0 Temprano. Hacia la personalizaci\u00f3n de la pr ofilaxis de la trombosis venosa profunda en pacientes pedi\u00e1tricos afectos de leucemia linfobl\u00e1stica aguda: uso de test de generaci\u00f3n de trombina. (PI17/00356). Instituto de Salud Carlos III (ISCIII). 2018-2022. IP: Rub\u00e9n Berrueco Moreno. Implement aci\u00f3n de de tratamiento Alltogether para leucemia linfobl\u00e1stica aguda pedi\u00e1trica en Espa\u00f1a. Fundaci\u00f3n Uno Estudio de fase 1/2, abierto y de un sol o brazo que eval\u00faa la seguridad y eficacia del ponatinib para el tratamiento de leucemias o tumores s\u00f3lidos recurrentes o refractarios en pacientes pedi\u00e1tricos. An Open-Label, Single-Arm, Phase 1/2 Study Evaluating the Safety and Efficacy of Ponatinib for the Treatment of Recurrent or Spain, S.L. 2021. IP: Albert Catal\u00e0 Temprano. Estudio de f ase 1/2 multic\u00e9ntrico para evaluar la seguridad y eficacia de KTEX19 en sujetos pedi\u00e1tricos y adolescentes con leucemia linfobl\u00e1stica aguda de precursores de linfocitos B recidivante/ refractaria o no A Phase 1/2 Multi-Center Study Evaluating Estudio en f ase III, aleatorizado, abierto, con control activo, multic\u00e9ntrico, para evaluar la eficacia y la seguridad de Crovalimab frente a Eculizumab en pacientes con hemoglobinuria parox\u00edstica previamente con inhibidores del A Phase III, Randomized, Open-Label, Active-Controlled, Multicenter Study Evaluating The Efficacy Versus Eculizumab In Adult And Adolescent International Ltd. 2021. IP: Albert Catal\u00e0 Temprano. Un estudio de f ase III, abierto, de un solo grupo, multic\u00e9ntrico de Ravulizumab junto al mejor tratamiento sintom\u00e1tico en participantes pedi\u00e1tricos (de 1 mes a <18 a\u00f1os) con microangiopat\u00eda tromb\u00f3tica (MAT) despu\u00e9s de un trasplante de c\u00e9lulas madre hematopoy\u00e9ticas (TCMH). A Phase 3, Open-label, Single Arm, Multicenter Study in Addition to Best Supportive Care in Pediatric articipants (from 1 month to < 18 years of age) with Thrombotic SELECTED PUBLICATIONS JE, C, Rives S, Myers GD et al. Pooled safety analysis of tisagenlecleucel in and young Rio P, Sanchez R, Zubicaray J, Galvez E et al. Hematopoietic Stem Cell Collection for the Gene Rives S, Cas tell\u00e0 M, Alonso A, Ben\u00edtez D, Caballero M et al. CART19-BE-01: A Multicenter Trial forward. Lancet EJ, Szvetnik A et P \u00e9rez S, Esperanza E, Vicente C, Torrebadell M, Jim\u00e9nez A et al. Measurable Residual Disease Assessed by Flow-Cytometry expression of is modified in both solid and liquid tumours and it is not uncommon to find that subtypes responsible hCNT1, levels This 66 PEDIATRIC SCIENCE AREA PAEDIATRIC CANCER circumstance, metabolic reprogramming, can also of year, our group's foremost contribution was the demonstration the fact that loss of expression of hCNT1 in a wide range of tumours has an epigenetic origin associated with the deregulation of the expression pattern and part of the function of this drug transporter, and this contributes to of the cellular response to these anti-tumoural agents. We believe this is a new epigenetic mechanism may condition C\u00e1rdenas, Jose Antonio Ag\u00fcero Aida Mata Ventosa, Nerea Urtasun Plans PHD STUDENTS Andrea Valentina Prieto PROJECTS Desoxiribonucle\u00f2sids com a ter\u00e0pia en POLG i altres gens (97/C/2020). Fundaci\u00f3 La Marat\u00f3 de TV3. Ajuts econ\u00f2mics a projectes de recerca de la Fundaci\u00f3 Marat\u00f3 de TV3. 2021- 2024. PI: Mar\u00e7al Pastor Anglada. nuevos tratamientos Inmuno- Oncol\u00f3gicos (RTC2019-006865- 1). Ministerio de Economia y Competitividad. Convocat\u00f2ria Reptes-Col\u00b7laboraci\u00f3 del Programa Estatal de Recerca, Desenvolupament i als Reptes de la Societat. PI: Mar\u00e7al Anglada. industrials (NT), metabolismo de nucle\u00f3tidos y c\u00e1ncer (RTI2018- 094655-B-I00). Ministerio de Ciencia, Innovaci\u00f3n y Universidades. Convocat\u00f2ria d'ajuts del Programa Estatal d'Investigaci\u00f3, Desenvolupament i Mar\u00e7al Pastor Anglada SELECTED PUBLICATIONS Boces C, Mata A, Mart\u00edn M, Boix L, Gir onella M, Pastor M et al. E, Lajarin M, Mat a Perez S, Fern\u00e1ndez F. Dexamethasone- IF:6,321. (Q1). Pena E, Mat a A, Laura V, P\u00e9rez S, Fern\u00e1ndez F. The Physicochemical, Biopharmaceutical, and group was founded in late 2020 with the overall goal to identify specific epigenomic vulnerabilities of developmental tumours, and to of personalised therapies to improve patient welfare and prognosis. We believe that one size does not fit all, and we need to treat each individual, not the have been granted the \"Programa Estatal de I+D+i Orientada a los Retos support develop this project. Additionally, we have incorporated new members into the group and expanded our national and international collaborator network: together we will bring about change los tumores rabdoides - definir para tratar. (PID2020-118241RA-I00). Ministerio de Econom\u00eda Y Competitividad (MINECO). 2021- 2024. IP: Alexandra Avgustinova. Ayudas par a Cajal (RYC) 2019. Beneficiario: Alexandra Avgustinova. (RYC2019- 027738-I). Ministerio Alexandra Avgustinova.1 FOREWORD numbers 2020 Global numbers 2020-2015 Institutional awards 7.1 MEDICINE AND PEDIATRIC SCIENCE AREA 7.1.4 medicine in rare diseases Metabolic and mitochondrial medicine Neurogenetics and molecular medicine Human molecular genetics I Human molecular genetics II Genomics for the diagnosis of rare diseases Diagnostic and therapeutic imaging68 INSTITUT DE RECERCA MEDICINE AREA PRECISSION MEDICINE IN RARE Metabolic and mitochondrial medicine Rafael Artuch Iriberri, MD, PhD Our research group participated in 32 scientific publications in 2021 and here we will mention those led by members of our team and those which are of special scientific significance. In the field of mitochondrial disorders, we should point out our participation in the first epidemiological study of this type of diseases at national level (Bellusci et al., Genes 2021), and the development of a new biomarker for the study of mitochondrial disorders research project on pathologies, PI20/00340, for the Carlos III Health Institute (ISCIII). In the sphere of technological development, we culminated the generation of a new biosensor for the measurement of ammonium, which is currently under testing at our hospital, through a health technologies development project. Additionally, we consolidated our metabolomic platform for research on cellular and animal models, which has given rise to four collaborative high-impact publications with basic to congenital disorders of glycosylation, we continued to expand of (PMID: 34140212; PMID: 34442375) episodes of cerebellar associated and which may and prognostic biomarker an accessible 32681750). Likewise, our collaboration with groups from Pompeu Fabra University (UPF) (Dr Fern\u00e1ndez Fern\u00e1ndez and Dr Gallego) allowed the development of a yeast and human cell Jaume Mercedes Serrano Gimar\u00e9, Camila Garc\u00eda Volpe, Rosa Gassi\u00f3 Subirachs, Aida Ormazabal Herrero, Cristina Sierra March POSTDOC ASSOCIATED RESEARCHERS Mercedes Casado Rio, Raquel Montero S\u00e1nchez, Juan Dar\u00edo Ortigoza PHD STUDENTS M\u00f3nica Centeno Pla, Abraham Jos\u00e9 Paredes Fuentes ASSISTANT RESEARCHER Gregorio Alexander Nolasco Tovar, Iria Trasobares Tania Pardal Chofle SELECTED PROJECTS Secuenciaci\u00f3n de ex oma para el diagn\u00f3stico de pacientes con enfermedades mitocondriales: investigaci\u00f3n de aspectos fisiopatol\u00f3gicos y terap\u00e9uticos de las deficiencias de conezima Q10. (PI20/00340). La de TV3. PI: Aida Ormazabal Herrero. Progr ama MIMeS_Detecci\u00f3n, prevenci\u00f3n y tratamiento precoz de Salud Mental en pacientes con Malalties Minorit\u00e0ries seguridad, tolerabilidad, farmacocin\u00e9tica y farmacodinamia de RO7248824 en participantes con S\u00edndrome de Angelman. An open-label, multicenter study to investigate PI: Mercedes Serrano Gimar\u00e9. Estudio de f ase IV, abierto y de una sola cohorte, de los resultados neurocognitivos (NC) a largo plazo en ni\u00f1os de 4 a 5 a\u00f1os con fenilcetonuria tratados con dihidrocloruro de sapropterina (Kuvan\u00ae) durante Rajan DS, Fortuna TR, Ander son EN, Ward C, Lee Y et al. Loss of function mutations in IF:14,919. (Q1). Pe\u00f1a M, Rold\u00e1n G, P erez J, Ortu\u00f1o FM, Carmona R, Aquino V et al. CSVS, a crowdsourcing database P arras A, Santos M, Pose J, Castro M, Fraga E et al. CPEB alteration and AREA PRECISSION MEDICINE IN RARE DISEASES Neurogenetics and molecular medicine Janet Hoenicka, PhD & Francesc Palau Mart\u00ednez, MD, PhD The Neurogenetics and Molecular Medicine (NeuroGene) Group does research the genetic, pathophysiological and therapeutic aspects of disorders affecting the central with special emphasis on rare diseases, and development disorders. The milestones reached the areas of basic and biomedicine and clinical research included the the susceptibility to Parkinson's disease. Disco very of new genes related to complex forms of autism Institute of Rare Diseases (IPER) and the Genetic Medicine Service of Sant Joan de D\u00e9u Barcelona Children's Hospital (HSJD), and publication of the preliminary results. national and international of Rare Diseases Research (CIBERER); (ii) collaboration with the Genomic Sciences and Precision Medicine Center (GSPMC), Medical College of Wisconsin; (iii) member of the International Parkinson's Disease Genomics Consortium (IPDGC) and only GP2 (Global Parkinson's Genetics Program); (iv) member of the Academy of Sciences of Latin America (ACAL); and (v) editor-in-chief, Orphanet Journal of Rare Diseases . In the sphere of training activity, four final master's degree projects and three final bachelor's degree projects were carried out by students of the University of Barcelona (UB), the Autonomous University of Barcelona (UAB) and Pompeu Fabra University (UPF). MEMBERS STAFF RESEARCHER Joan Maynou Fern\u00e1ndez, M\u00f3nica ASSOCIATED Mar Capdevila, Cristina Hernando Davalillo, Laura Marti Sanchez, Maria Rodriguez Sanz, Jordi Yaiza D\u00edaz Osorio, Adri\u00e1n Alcal\u00e1 San Mart\u00edn, Jodie Kane, Alba Pascual Rodr\u00edguez, Merc\u00e8 Bolasell Girgas, Antonio F Martinez Monseny TECHNICIAN Daniel Castillo Mestres, Jordi Genov\u00e8s Escarr\u00e9 70 INSTITUT DE RECERCA MEDICINE AND PEDIATRIC SCIENCE PRECISSION MEDICINE IN RARE DISEASES SELECTED PROJECTS Mitochondrial membrane dynamics and its Investigaci\u00f3n - MICINN, 2021-2024. PI: Francesc Palau Mart\u00ednez. Genes y fenotipos de s\u00edndr omes parkinsonianos: estudio cl\u00ednico y experimental. (PI19/00126). Instituto de III (ISCIII). 2020- 2022. PI: Janet Hoenicka. Infraes tructura de Medicina de Precisi\u00f3n asociada a la Ciencia y Tecnolog\u00eda (IMPaCT). Ciencia de datos. Instituto de Salud Carlos III (ISCIII). 2021-2023. PI: Joan Maynou Fern\u00e1ndez. El cer ebro cl\u00ednico del s\u00edndrome Coffin-Siris: estudio integral de un trastorno del neurodesarrollo. Hospital Sant Joan de D\u00e9u - Esplugues HSJD. 2020-2023. PI: Francesc Palau Mart\u00ednez. Pro yecto de investigaci\u00f3n traslacional sobre los aspectos fisiopatol\u00f3gicos y cl\u00ednicos de la enfermedad de Menkes. (Amigos de Nono). Fundaci\u00f3n amigos de nono contra la enfermedad de Menkes. 2017-2022. PI: Francesc Palau Mart\u00ednez y Janet Hoenicka. Pro yecto piloto sobre la implementaci\u00f3n de un cribado neonatal gen\u00e9tico en Espa\u00f1a. Fundaci\u00f3n Ram\u00f3n Areces. 2019- 2022. PI: Francesc Palau Mart\u00ednez. Application of Adv anced multimodal microscopy imaging era-Treg\u00f3n Exp\u00f3sito J, Carrera- Garc\u00eda L et I, Puente J et al. Regulatory rare variants of the dopaminergic gene ANKK1 Benito D, Ortez CI, Altimir A, Osuna M et al. Translational Diagnostics: an in-house pipeline to validate genetic variants In 2021 syndrome, and iPSCs the former derivation of neurons and organoids. Likewise, we functionally analysed effect in the SOST gene in relation to osteoporosis, and mutations in the monogenic disorders of high and low bone mass, and on functional validation in genetic diseases of the genetic factors involved in stroke recovery, we have identified a in the migration of neutrophils through the blood-brain barrier, which the of variants We have studied lie behind various psychiatric and neurological disorders of complex nature. On the one hand, the genetic analysis of a murine model of cocaine dependence, which allowed us to propose a new pharmacological target for relapse (the protein PLCB1), and on the other hand we have investigated the epigenetics of drug addiction, identifying genetic risk Lastly, we made progress in the of generating and neuronal POSTDOC ASSOCIATED RESEARCHERS Raquel Rabionet Fern\u00e1ndez Castillo, N\u00faria Gil RESEARCHER Fundaci\u00f3 Marat\u00f3 Effects os y funcionales hacia aproximaciones terap\u00e9uticas para varias enfermedades \u00f3seas y s\u00edndromes de discapacidad intelectual (PID2019- 107188RB-C21). Ministerio de Ciencia, Innovaci\u00f3n y Universidades. 71 INSTITUT DE RECERCA MEDICINE AND PEDIATRIC SCIENCE AREA PRECISSION MEDICINE IN RARE Convocat\u00f2ria d'ajuts Programa Estatal d'Investigaci\u00f3, Desenvolupament Innovaci\u00f3n y Universidades. RETOS. 2019-2021. PI: Roser Corominas. SELECTED PUBLICATIONS Cabana J, Mart\u00edn E, Gallego A, Maldonado R, F ernandez N, Cormand B. \u00d6, Prat A, Bullich G, Matalonga L et al. De Novo PORCN and ZIC2 Mutations in a Highly Consanguineous Family. Int. J. Mol. Als polygenic Cozar M, Gar cia N, Ovejero D, Nogu\u00e9s X et al. Genetics and Genomics of Functional Analysis of Variants and Mol. molecular genetics II Gemma Marfany Nadal, PhD Our group's two main lines of research comprise, on the one hand, the further development of the genetic testing of rare diseases of the retina, and on the other hand, the generation of animal models to study the function of the genes that cause such diseases, together with the search for a possible precision apply NGS techniques retinal dystrophies within the spin-off generated as transfer of knowledge, achieving a success rate of up to 85%. In order to study the molecular bases of hereditary blindness, we recently generated model mice few months, we have been conducting molecular studies in greater depth with a view to elucidating why the mutations in these genes cause hereditary blindness. For the gene NR2E3, we have identified isoforms generated by alternative splicing which had not been present respect to the control (collaboration with Dr Vaquerizas in M\u00fcnster). As concerns CERKL, we have collaborated with other groups of the IBUB and the IRSJD (Dr Villaroya and Dr Artuch) to that its causes regulation of mitochondrial metabolism. A senior postdoc of the made stays in Naples (collaboration formation and stability of the sensory cilium, means that candidate causes of ciliopathies, of which retinal neurodegeneration is one of the symptoms. In the future we plan to pursue in greater depth the new paths of research that have been opened during this year. 2021 has been a year of intense work, with the establishment of new national and international collaborations which, it is hoped, will soon be coming Elena Borrego SELECTED PROJECTS Explorando las v\u00edas de se\u00f1alizaci\u00f3n neur osensoriales en enfermedades hereditarias de retina como posible aproximaci\u00f3n a la terapia (PID2019-108578RB-I00). Ministerio de Ciencia, Innovaci\u00f3n y Universidades. Convocat\u00f2ria d'ajuts del Programa Estatal d'Investigaci\u00f3, Desenvolupament i DBGEN Ocular Genomics, S.L. 2018-2023. PI: Gemma Marfany Nadal. Enfermedades Rar as (CB06/07/0041). Ministerio Sanidad y Consumo. Convocat\u00f2ria d'ajuts destinats a finan\u00e7ar estructures estables d'investigaci\u00f3 cooperativa, a l'\u00e0rea de biomedicina i ci\u00e8ncies de la salut, en el marc del Programa Ingenio 2010, Programa Consolider, accions CIBER. 2006 - 2022. PI: Gemma Marfany Nadal. PUBLICATIONS A\u00edsa I, Garc\u00eda R, Mirr a S, Marfany G. The Alter Retina: Alternative Splicing of Retinal Genes in Health and Disease. Int J Mol Sci. 2021;22(4):1855. IF:5,923. (Q1). Garc\u00eda-Arr oyo Gavalda Dom\u00e8nech EB, Gavalda A, Herrera C, Oliva C CERKL, a retinal dystrophy gene, regulates mitochondrial IF:5,996. (Q1). S\u00e1nchez L, G. Track: PEDIATRIC SCIENCE AREA PRECISSION MEDICINE IN RARE DISEASES Genomics for the diagnosis of rare diseases Judith Armstrong Mor\u00f3n, PhD The Genomics for Diagnosis of Rare Diseases group is a recently organised unit at the Sant Joan de D\u00e9u Barcelona Research Institute (IRSJD). It focuses on genomic tools and their potential for specifically within the framework of neurological disorders but also with respect to other rare diseases of genetic origin. NGS technology for the detection of mutations causing neurological pathologies began to be implemented at our hospital in 2013, and this experience has been extended to include the rest of the specialities treated at our institution. This technological knowledge and the knowledge of neurological disorders and other diseases led to creation of our research group. Our main goal is to transform clinical diagnosis into genetic-molecular diagnosis and to achieve our we use mass sequencing technology, employing not only genomic data but also Mass of data which are highly useful in the hospital sphere and this is why we also focus on and lead a research project conceived TECHNICIAN Carlota Ros Bonaventura, Paola Pacheco Fern\u00e1ndez SELECTED PROJECTS Catalan Network of Genetic Diagnosis 2021-2024. PI: D\u00e9lia Yubero Siles. Estudio de pacient es Espectro Rett mediante un enfoque multi\u00f3mico integrativo: delucidar la huella molecular de la via funcional. (PI20/00389). Instituto de Salud Carlos III (ISCIII). 2021-2023. PI: Judith Armstrong Mor\u00f3n. Convoc at\u00f2ria Ainhoa Pascual (co-financiado Mor\u00f3n. SELECTED PUBLICATIONS Barbosa S, V\u00e1zquez ME, Gonzal ez E, Hermida \u00c1, Valverde LL, Armstrong J et al. Characterization of a Novel Splicing Variant in Acylglycerol Kinase (AGK) Associated with Int. J. Sci. 2021;22(24):13484. IF:5,923. (Q1). Pascual Martinez T, Xiol C, Arms trong J. MECP2-Related Disorders in Males. Int. J. Mol. Sci. 2021;22(17):9610. IF:5,923. (Q1). Xiol C, Marina T, Pascual A, De Oy arzabal AL, Armstrong J. Technological Improvements in the Genetic Diagnosis STAFF Marta G\u00f3mez Chiari, Emilio Inarejos Clemente, M\u00f3nica Rebollo PoloSELECTED PROJECTS Sistema de ayuda a la decisi\u00f3n cl\u00ednic a para la evaluaci\u00f3n y predicci\u00f3n de enfermedad vascular cerebral pedi\u00e1trica: Radi\u00f3mica a partir de RM vascular e Inteligencia Artificial (Vascul\u00f3mica). (PI20/00296). Instituto de Salud Carlos III Munuera del Cerro. Plataf orma ISCIII de apoyo a la I+D+I en Biomedicina y Ciencias de la Salud. Biomodelos-Impresi\u00f3n 3D. (PT20/00090). Instituto de Salud Carlos III Catalunya. 2020IP:Jose Luis Munuera del Cerro. SELECTED PUBLICATIONS Gonzalez E, Grau L, Ferrero SI, Hernandez A, Reboll o M, Marta C et al. Pessary for Management Su\u00f1ol H, Colbert RA, Akikusa J et al. Consensus-driven conceptual development of a standardized whole body-MRI Gill AE, Hawkins CM, Mac\u00edas N, Inarejos E Global numbers 2020-2015 Institutional awards 7.1 MEDICINE AND PEDIATRIC SCIENCE AREA 7.1.5 Applied clinical research Influence of the on welfare Hospital dentistry and periodontal medicine Paediatric AND PEDIATRIC SCIENCE AREA APPLIED CLINICAL RESEARCH Influence of the environment child welfare Carles Cubells, MD, PhD took in two non-competitive research projects funded by Quick Joan Montaner Villalonga -Seville Biomedical Research Institute. Funding: Mutua Madrile\u00f1a Foundation. 2020-22. PI: Carles Luaces / V Trenchs. Meningitis screening a no vel, non-invasive, transfontanellar ultrasound device using machine learning techniques: a Funding: New Born Solutions has provided funding. The participation of the Rabat HER in the study is co-financed by the Spanish International Development Cooperation Agency (2019/ pointed out that a significant part of the group's research has been focused on the impact of the SARS-CoV 2 pandemic on the its effects on Moreover, along the same line, we collaborated actively on the promotion of the good handling of children and on the prevention of mistreatment during the lockdown period, participating in endorsed by the Paediatric on Child Mistreatment for Healthcare Professionals\"]).MEMBERS STAFF RESEARCHER Gemma Claret Teruel, Ana Isabel Curcoy Barcenilla, Lidia Mart\u00ednez S\u00e1nchez, Victoria Trenchs Sainz de la Maza POSTDOC ASSOCIATED RESEARCHERS Andrea Aldemira Liz, Vanessa Arias Constant\u00ed, Eva Burriel, Cristina Parra Cotanda PHD STUDENTS Vilarrubi, Marta Sim\u00f3 Nebot SELECTED PROJECTS STEPS_Step by s tep standing up a Barnahus in Catalonia: A simulation-based program to avoid secondary victimization in the assessment and treatment of child sexual abuse. European Commission. 2020-2022. IP: Marta Sim\u00f3 Nebot. Estudio pr sobre la hidrataci\u00f3n y nutrici\u00f3n en pacientes pedi\u00e1tricos con enfermedad avanzada. Sociedad Espa\u00f1ola de cuidados paliativos pedi\u00e1tricos (PEDPAL). 2019-2021. IP: Sergi Navarro Vilarrubi. La experiencia de l os profesionales como segundas v\u00edctimas: estudio descriptivo. Sociedad Espa\u00f1ola de Urgencias de Pediatr\u00eda. 2021. IP: Dra. Vanessa Arias Constant\u00ed. SELECTED PUBLICATIONS McGregor S, Marneni SR, Katsut a T, Griffiths MA, Hall JE et al. Willingness to Vaccinate Children against Influenza after the Coronavirus Disease Pediatr. et al. Factors associated with parents' willingness to enroll their Vaccin Immunother. 2021;17(6):1607-1611. IF:3,452. (Q2). D, Mir \u00f3 \u00d2, Galicia M, Superv\u00eda A, Puiguriguer J, Ortega J et al. Spanish Research Network on Drugs in Hospital Emergency Departments - the REDUrHE 2021;33(5):335-344. IF:3,881. (Q1). Superv\u00eda A, Salgado E, C\u00f3rdoba F, Garc\u00eda L, Mart\u00ednez L, Moreno A et al. Poisoning cases in Catalonia: characteristics according to age groups 2021;33(2):115-120. IF:3,881. (Q1). Hospital dentistry and Alejandro MD, PhD We have kept up our efforts along our group's lines of work, starting up three new studies, one in each of our and they are preparatory procedures for the doctoral theses of the first authors. MEMBERS STAFF RESEARCHER Mireia Aznar G\u00f3mez, Lluis Brunet Llobet, Jaume Miranda Rius, Jordi Moncunill Mira, Maria Llu\u00efsa Camps SELECTED PROJECTS SGR Brunet LL, Cuadras D, Lor ente N, Pascal R, Rovira C et al. Do the clinical criteria used AREA APPLIED CLINICAL RESEARCH Joan Prat Bartomeu, MD, PhD MEMBERS STAFF RESEARCHER Elisa Carreras Bertran, Ester Casas Gimeno, Jaume Catal\u00e0 Mora, Jes\u00fas D\u00edaz Cascajosa, Ana Isabel D\u00edaz Cort\u00e9s, Carlos Fresno Ca\u00f1ada, Carmen Garc\u00eda de Vicu\u00f1a Mu\u00f1oz, Enrique Jimenez Ga\u00f1an, Ana Llorca Carde\u00f1osa, Marta Morales Ball\u00fas, N\u00faria Planas Dom\u00e8nech, M\u00aa Josep Planas Tapias, Enric Puigvent\u00f3s, Romeu fase I, unic\u00e9ntrico, abiert o y de escalado de dosis, para evaluar la seguridad y la actividad del adenovirus oncol\u00edtico VCN-01 en pacientes con retinoblastoma refractario. (FSJD-RTB-2015). Fundaci\u00f3 Privada per a la Recerca i la Doc\u00e8ncia Sant Joan de D\u00e9u - FSJD; VCN Biosciences S.L. 2017-. IP: Jaume Catal\u00e0 Mora. Estudio pos tautorizaci\u00f3n, multic\u00e9ntrico, multinacional, longitudinal y observacional para el registro de la seguridad en pacientes tratados con voretig\u00e9n neparvovec. (CLTW888A12401/ NOV-LUX-2019-01). Novartis Farmac\u00e9utica, S.A. 2020-. retinoblastoma: analysis of 1024 patients from 43 countries and patients M, Desbrousses E, Kiv el\u00e4 TT, Mallipatna A, Zhang C et al. Global Treatment Outcomes: Association with National Income Level. Ophthalmology. 2021;128(5):740- 753. IF:12,079. Research in Lahuerta Valls, RN, PhD Methodological support for nurse-led research projects in 2021. 2021 a year of transition towards normalisation of situation of coexistence For us nurses who engage in clinical research and who form part of the associated clinical groups programme, this has allowed us to conduct translational research primarily oral c ommunications in national congresses and conferences. 20 post ers in national congresses and conferences. 7 post ers in international congresses and conferences. 5 publications in scientific journals. 2 awards. 2 competitiv Continuity of the resident intern nurses of in the new approach to the final residency project led by the Research Nurse: - The nurse r esidents of the graduating class of 2020-2022 are introduced to research skills in the research lines established by the Nursing Management. - They submit t o the Research Nurse the various parts of their research projects in order to receive assessment and orientation, for the purpose of achieving the required research skills. - They ar e introduced to the procedure for applying for the assessment and approval of the Research Committee of the Sant Joan de D\u00e9u Barcelona Research Institute (IRSJD), and for obtaining the assessment of the Ethics Committee for Research with Medicines (CEIm). Methodologic al support for projects: Effectiveness of a nursing staff intervention for of paediatric onco- MEMBERS STAFF RESEARCHER Maribel Ferrer Orona, Concepci\u00f3n Agust\u00edn Mata, Silvia Cipr\u00e9s Roig, Encarna G\u00f3mez Gamboa, Jordi Mitj\u00e0, Gemma P\u00e9rez Acevedo POSTDOC ASSOCIATED RESEARCHERS M\u00aa PHD Molina SELECTED PROJECTS Seroprevalencia de la infecci\u00f3n por SARS-CO V-2 en los empleados del hospital matenor-infantil Sant Joan de D\u00e9u. (PR-440/2020). Fundaci\u00f3 Infermeria i Societat. 2021-2021. IP: Laura Lahuerta Valls. An\u00e0lisi de l'espiritualit at, religiositat o filosofia de vida dels pares i mares d'infants amb 76 INSTITUT DE RECERCA MEDICINE AND PEDIATRIC SCIENCE APPLIED CLINICAL RESEARCH IP: M\u00aa Dolors Navarro Rubio. Eficacia y seguridad de l os \u00e1cidos grasos hiperoxigenados en la microcirculaci\u00f3n de la p\u00farpura fulminante en pacientes con sepsis. (PR-242/17). Fundaci\u00f3 Infermeria i Societat. 2018-2021. IP: Gemma P\u00e9rez Acevedo. Pre venci\u00f3n de complicaciones de herida quir\u00fargica en paciente pedi\u00e1trico: efectividad de la ter\u00e0pia de presi\u00f3n negativa incisional en cirug\u00eda de escoliosis no idiop\u00e1tica (Estudio TePreInPed). Beca Peris 2021-2025 (SLT017/20/000194). IP. Gemma P\u00e9rez Les narrativ es de la mort: e de les cures infermeres en la qualitat assistencial i seguretat dels pacients, segons el model de Mitchell. Beca Enfermeria i Societat. IP: Immaculada Rodr\u00edguez Salamanca. SELECTED PUBLICATIONS Moreno C, Roy C, Monforte C, Gonz\u00e1l ez L, Navarro MD, Gallart (Q2). Martinez A, Negre A, Lahuerta L. Pediatric Patient Transfer from a Tph Ward to Icu: numbers 2020-2015 Institutional awards 7.2.1 Mental health and society7.2 MENTAL HEALTH AREA Epidemiology of mental disorders and aging Health technology assessment in primary care and mental health (PRISMA) Psychological research group on fibromyalgia and chronic pain (AGORA group)78 INSTITUT DE RECERCA MENTAL HEALTH AREA MENTAL HEALTH AND SOCIETY Epidemiology of mental disorders and aging Josep Maria Haro Abad, MD, PhD & Ai Koyanagi, MD, PhD In 2021, the Epidemiology Mental Health Disorders and Ageing group worked on various national and international projects. It coordinates two projects funded by the European Commission's Horizon 2021 which purpose of developing and testing a digital platform for the promotion and improvement of mental health at the workplace; SYNCHROS whose purpose cohort data harmonisation processes, and which will be completed around mid-2022. Dr Haro leads one of the 36 scientific research projects of excellence that have received funds raised by the 2020 telethon programme La Marat\u00f3 de TV3. The selected project is called REPICAL and its purpose is to achieve an understanding of the needs and working conditions of the staff in nursing homes with the aim of favouring the well-being of the elderly or disabled people who live there. Notable among the principal results obtained in 2021 are the main findings of the \"Age with Health\" study, which show that social support has an effect on feelings of loneliness, bringing about a significant reduction of the probabilities of relapse or prolongation of major depression episodes. In the MINDCOVID study, research has been conducted on feelings of disaffection towards social relations as one of the main risk factors of depression, anxiety and suicidal ideation contributed the circumstance that the former show a greater prevalence of mental health problems. MEMBERS STAFF RESEARCHER Santiago Palomo Conti, Jacob Louis Etienne Charles, Amanda Lloret Pineda, Laura Fincias, Lydia Hanaa Faris, Gemma Riquelme Alacid, Marta Franch Roca, Anna Ferrer Elena Condominas Casanovas, Iago Gin\u00e9 V\u00e1zquez, Crist\u00f3bal EDHEN: European Health Dat a and Evidence Network. European Commission. 2021-2022. PI: Josep Maria Haro Abad. Xarxa EMPOWER_Eur European Commission; Fundaci\u00f3 Privada per a la Recerca i la Doc\u00e8ncia Sant Joan de D\u00e9u - FSJD. 2020-2023. PI: Beatriz Guzm\u00e1n. PUBLICATIONS Felez M, Haro JM, Stubbs B, Gin\u00e9 I, Liu I, Y ucel R, Nai M, Morena M et al. Are environmental pollution and biodiversity levels associated to the JM, Stickley A, Koyanagi A. Relationship sexual orientation in IF:7,723. (Q1). Smith L, Shin JI, Ghayda RA, Hijaz A, Sheyn D, P ope R et al. Physical Ageing. 2021;50(6):2038-2046. IF:10,668. (Q1). Health technology assessment in primary care and mental health (PRISMA) Maria Rubio Valera, PhD & Antoni Serrano Blanco, MD, PhD In 2021, the PRISMA group carried out over 30 projects. Additionally, it began to prepare a database of unit costs at national level to inform health economy studies, and it started up two European projects. One of these European projects is funded by a starting grant from the European Research Council (ERC). Its purpose is to carry out a cluster clinical trial of an intervention have been the year. The other project with European funding is focused on the performance of a study of the implementation cost and of the cost-effectiveness of an intervention to reduce the cancer diagnosis time in three Latin American countries. As concerns our principal results in 2021, was carried out in 8 autonomous regions in Spain. This study involved a major process of harmonisation of data from different healthcare systems. 79 INSTITUT DE RECERCA MENTAL HEALTH AREA MENTAL HEALTH AND SOCIETY Likewise, we demonstrated in a pilot study that the intervention shared on for professionals medication. that 9% of the treatments prescribed to the paediatric population in Catalonia are of initial medication non-adherence differed according concerned. Specifically, younger medication non-adherence, while children between 5 and 11 age showed the lowest initial Mental Health Primary Care Support Programme in Catalonia based on the experience of primary care physicians and mental health professionals. We also carried out the project called \"Design of an action plan for improving the quality of services and mental health in the Baix Llobregat Region\", which was commissioned by the Barcelona Provincial Council, using a participative action methodology. Bank, an NGO whose purpose is to cover the price of medication for citizens who cannot afford it), to identify the profile of the beneficiaries of this organisation, and to determine the pattern of use of the covered medications Balad\u00f3n Higuera, Vanessa Barneda, Laura Gonz\u00e1lez Su\u00f1er, Maria Iglesias Gonz\u00e1lez, Cristina L\u00f3pez Ortiz, Carlos Pe\u00f1a Salazar, S\u00edlvia Ram\u00edrez Perdomo, Enric Vicens Pons POSTDOC ASSOCIATED RESEARCHERS Ignacio Aznar-Lou, M\u00aaMontserrat Gil Girbau, Alexandra Dima and Merc\u00e8 Soler Font PHD STUDENTS Paula Arroyo Uriarte, Ana Mar\u00eda Besoa\u00edn Cornejo, Cristina Carbonell Duacastella, Marina Fuente Moreno, Carmen Corral Partearroyo, Alba S\u00e1nchez Vi\u00f1as TECHNICIAN Marcos Antonio Catalan Vega COLLABORATOR RESEARCHER Mar\u00eda del Carmen Gallardo Gonz\u00e1lez, Montserrat Iracheta Tod\u00f3, Ana Fern\u00e1ndez S\u00e1nchez, Ana Maria Jov\u00e9 Mass\u00f3, Maria Antonia March Pujol, Juan Manuel Mendive Arbeloa, Mar\u00eda del Carmen Olmo, Maria Teresa Pe\u00f1arrubia Mar\u00eda, Ramon Sab\u00e9s Figuera, Lu\u00eds of cancer: implementation research in different healthcare systems of Latin America. (965226). European Commission. 2021-2025. PI: Maria Rubio Valera. Evaluaci\u00f3n de la adher encia a antipsic\u00f3ticos a partir de datos de la pr\u00e1ctica cl\u00ednical real. (PI19/00111). Instituto de Salud Carlos III (ISCIII). 2020-2022. PI: Antoni Serrano Blanco. El probl ema de la no iniciaci\u00f3n pedi\u00e1trica: Evaluaci\u00f3n con m\u00e9todos mixtos. (PI19/00108). Instituto de Salud Carlos III (ISCIII). 2020-2022. PI: Maria Commission. 2021-2025. PI: Maria Rubio Valera. SELECTED PUBLICATIONS Arias J, Vilagut G, Ronaldson A, Serrano A, Mart\u00edn V, P eters M et al. Prevalence and variability of current depressive disorder in 27 2021;6(10) IF:21,648. (Q1). Aznar I, Zabalet a E, Casajuana M, S\u00e1nchez A, Parody E, Bol\u00edbar B et al. Cost-effectiveness analysis of a multiple health behaviour change intervention in people aged between 45 and 75 years: a cluster randomized controlled trial in primary Phys 88. IF:6,457. (Q1). Iglesias M, Gil M, Pe\u00f1arrubia MT, Blanc o E, Fern\u00e1ndez R, Serrano A et al. Barriers and opportunities for the treatment of mild-to-moderate Marqu\u00e9s S, P e\u00f1arrubia MT, Urbanos RM, Borrell C, Bosch J et al. Who Suffers From Pharmaceutical Poverty and What Are Their Needs? Evidence From a Spanish Region. FRONTPHARMACOL. 2021;12:617687-617687. In 2021, the most important development for our team was the establishment of a double affiliation agreement of our PI to the Autonomous University of Barcelona (UAB) and the Sant Joan de D\u00e9u Barcelona Research Foundation (FSJD) thanks to the understanding reached between these two institutions. Since September 2021, Dr Luciano has been a teacher in the Clinical Psychology and Health Department of the UAB. Over the course of the year, our group has mainly focused its efforts on two clinical and Adri\u00e1n P\u00e9rez Aranda80 INSTITUT DE MENTAL HEALTH AREA MENTAL HEALTH AND SOCIETY PHD STUDENTS Juan Pablo Sanabria Mazo, Ariadna Colomer Carbonell ASSISTANT RESEARCHER Jaime Navarrete Hidalgo COLLABORATOR RESEARCHER Albert Feliu Soler, Xavier Borr\u00e0s Hern\u00e1ndez SELECTED PROJECTS Convocat\u00f2ria d'ajuts per a la c ontractaci\u00f3 de personal investigador novell (FI-2021). Beneficiari: Ariadna Colomer Carbonell. (2021_FI_B_00216). Agaur Devis. Contrat de formaci\u00f3n en investigaci\u00f3n en salud (PFIS). Beneficiari: Juan Pablo Sanabria. (FI20/00034). Instituto de Salud Carlos 2021-2024. Juan Vicente Luciano Devis. Cost e-utilidad y efectos fisiol\u00f3gicos de la Terapia de Acept\u00e1ci\u00f3n y Compromiso y la Activaci\u00f3n Conductual en pacientes con dolor cr\u00f3nico y depresi\u00f3n mayor com\u00f3rbida (Proyecto IMPACT). (PI19/00112). Instituto de Salud Carlos multinacional de caracter\u00edsticas cl\u00ednicas, incluida la progresi\u00f3n radiol\u00f3gica, y carga de la enfermedad durante 5 a\u00f1os en contextos de la vida real. Estudio PROOF. (10297). Abbvie Spain, S.L.U. 2014PI:Antoni Garc\u00eda J, Gude F, Luciano JV, F eliu A, Gonz\u00e1lez A et al. Impact of and on anxiety Collado C, Navarr o M, Adri\u00e1n A, L\u00f3pez Y, Garcia J, Montero stress reduction 2021;38(11):1138-1151. D, Mart\u00ednez C, Monreal A, Bar cel\u00f3 A, Campos D, P\u00e9rez Aranda A et al. Protective role of mindfulness, Modrego M, L\u00f3pez Y, Gar c\u00eda J, P\u00e9rez Aranda A, Navarro M, Beltr\u00e1n M et al. Efficacy of a mindfulness-based programme with and without virtual reality support to reduce stress in university students: Juan P ablo Sanabria M, Almirall M, Must\u00e9 M, Feliu A, M\u00e9ndez JL et al. Effectiveness numbers 2020-2015 Institutional awards 7.2.2 Scientific bases and approach to mental disorders7.2 MENTAL HEALTH AREA Etiopathogenesis and treatment of severe mental disorders (MERITT) Cerebral imprints of gender, development and pathology82 INSTITUT DE RECERCA MENTAL HEALTH AREA SCIENTIFIC BASES AND APPROACH TO MENTAL DISORDERS Etiopathogenesis and treatment of severe mental (MERITT) MD, in financed research projects, published articles with high impact factor, and collaborated with other centres. Moreover, we are leading different multi-centre projects in each of our research lines, the progress of which is reported in the resulting publications. The impact factor of our group grew with respect to previous years and the number of publications with the participation of other centres has increased as well. With respect to new grants, it may be pointed out that we obtained three research projects in the call of the Carlos III Health Institute, which are addressed to the study of traumatic experiences, the effectiveness of a family metacognitive intervention, effect of COVID on cognition. A project of collaboration with an enterprise has the effect of post-residence grant was awarded to a member of our group to allow continued training in research and the preparation of a doctoral thesis. Likewise, two other grants were awarded to two pre-doctoral members of our team so that they may make stays at other research centres abroad. MEMBERS STAFF RESEARCHER Noem\u00ed del Prado S\u00e1nchez, Jos\u00e9 Manuel Fern\u00e1ndez Rodr\u00edguez, Jaume Mart\u00ednez Mas, Alvaro Muro Alvarez, Aitor-Eneko Oliv\u00e9 Albiztur, Jes\u00fas P\u00e9rez Pazos, Mar\u00eda Jos\u00e9 Morcillo, Belen Ramos JoseMaria, Antonio Manuel Alba Mu\u00f1oz, Hilari Andres Mora, Belen Arranz Mart\u00ed, Adela Berrozpe Blasco, Emma Casas Anguera, Marta Coromina Sadurn\u00ed, Jorge Cuevas Esteban, Ruth Cunill Clotet, Gemma Escartin Martin, Gemma Escuder Romeva, Alexandrina Foix Sanjuan, Mar Garc\u00eda Franco, Marcia Iraz\u00e1bal Gim\u00e9nez, Francisco Mart\u00ednez Zambrano, Eva Miquel Fernandez, Mar\u00eda Trinidad Pel\u00e1ez Mart\u00ednez, Elena Rubio Abadal, Luis San Molina, Sonia Vilamala Anton POSTDOC ASSOCIATED RESEARCHERS America Jennifer Vera Montecinos, Helena Garc\u00eda Mieres PHD STUDENTS Desir\u00e9 Traver Edo, Luciana Beatriz Diaz Cutraro, Silvia Marc\u00f3 Garcia, Elia Vila Andreu ASSISTANT RESEARCHER Manuel Abella Villena, Jordi Galiano Landeira, Marta Dom\u00ednguez del Campo, Clara Serra Arum\u00ed, Marina Verdaguer Rodriguez, Marta Ferrer Quintero, Anna Butjosa Molines, Gabriel Ledesma Iparraguirre, Regina Vila Badia COLLABORATOR RESEARCHER Joan Costa Escol\u00e0, Maria Elena Huerta Ramos, Raquel L\u00f3pez Carrilero, Alfonso Monje Hern\u00e1ndez SELECTED PROJECTS Autoestigma i funcionament per i de D\u00e9u -Serveis de Salut Mental. 2021- 2022. IP: Judith Usall i Rodi\u00e9. Influencia del estil o de apego en la cognici\u00f3n social y sesgos cognitivos en personas con primeros episodios psic\u00f3ticos, esquizofrenia cr\u00f3nica y controles sanos. (PI18/00212). Instituto de Salud Carlos III (ISCIII). 2019-2023. IP: Susana Ochoa G\u00fcerre. Reguladores de la e xpresi\u00f3n g\u00e9nica como predictores de diagn\u00f3stico y biomarcadores de d\u00e9ficits cognitivos y cambios en el grosor cortical en psicosis de inicio reciente. (PI18/00213). Instituto de Salud Carlos III (ISCIII). 2019-2023. ell KS, A, Leza JC, Haro JM al. Kynurenine er-Quintero R, Birul\u00e9s I, Barajas A, Lorente-Rovira E et al. Persons with first episode psychosis have Serra-Arum\u00ed C, Es teban-Sanjusto M, Ochoa S et al. Types, prevalence and gender differences of childhood trauma in first-episode psychosis. What is the evidence that childhood trauma is related to symptoms and functional outcomes clinical personnel in different fields. For example, the joint research line with Dr Alfredo Garc\u00eda-Alix and Dr Thais Agut has allowed us to produce two scientific papers, one of which has already been accepted for publication in Archives of Disease in Childhood , while the other is currently under peer review. For its part, the research line on psychosis has produced a notable article, which reports various patterns of cognitive impairment in women, who are more susceptible to depression, and in men, who are more susceptible to anxiety. Other projects of interest are the joint analysis of 83 INSTITUT DE RECERCA MENTAL HEALTH AREA SCIENTIFIC BASES AND APPROACH TO MENTAL DISORDERS databases on neuroimaging in the psychiatric population, with the psychiatry research group of Hospital Sant Pau, and the collaboration with Dr Giovanni Frisoni (Fatebenefratelli, Italy) on the use of a database of data on Alzheimer's patients. MEMBERS STAFF RESEARCHER Antonio Callen Soto, Maria i neurol\u00f2gics. (05_2020). Parc Sanitari de Sant Joan de D\u00e9u -Serveis de Salut Mental. 2021-2022. PI:Maria Rosa Cambra Mart\u00ed. COGNIVITRA: COGNItive VIt ality TRAining at home. (AC18/00015). Instituto Privada per a la Recerca i la Doc\u00e8ncia Sant Joan de D\u00e9u - FSJD. 2020PI:Antonio Callen Soto. Estudio Pr ospectivo No Intervencionista De Pacientes Con Enfermedad De Alzheimer Leve A Moderada Y Sus Cuidadores En Cuatro Pa\u00edses Europeos. (MER-ALZ-2016-01). Merck, Sharp & Dohme de Espa\u00f1a. S.A. 2016PI:Antonio Callen Soto. SELECTED PUBLICATIONS Brebion G, Nu\u00f1ez C, Lombardini F, Carl S, S\u00e1nchez AM, Sar a S et al. Subclinical depression and anxiety impact verbal memory functioning differently in study. J Psychiatr Res. 2021;140:308-315. IF:4,791. (Q1). Mart\u00edn Bejarano M, Ruiz B, Zamor a B, Mart\u00ednez de Arag\u00f3n A, Garc\u00eda C, Jim\u00e9nez S et al. Actividad cerebral en j\u00f3venes infectados por el virus de la inmunodeficiencia humana por transmisi\u00f3n vertical: estudio piloto de resonancia magn\u00e9tica funcional. Rev Neurol. 2021;72(10):343-351. IF:0,870. (Q4). Quintas J, P ais J, Martins AI, Santos H, Neves L, Sousa S et al. CogniViTra, a Digital Solution to Support Dual-Task Rehabilitation IF:2,397. (Q3). 1 numbers 2020-2015 Institutional awards 7.3.1 Health technologies and innovation7.3 bioinformatics and biomedical signals biomaterials Innovation in health technologies85 INSTITUT DE RECERCA TRANSVERSAL PROGRAM HEALTH TECHNOLOGIES AND Jes\u00fas Escriv\u00e1 Mu\u00f1oz, Giovana Elizabeth Gavidia Bovadilla, Pedro Gomis STUDENTS Pol Canal Noguer, Flavio Palmieri, Maria Barranco Altirriba, Angela Lopez del Rio, Xavier Marimon Serra, Sergi Picart Armada ASSISTANT RESEARCHER Pol Gil Figuerola, Joshua Llano Viles, Pol Sola de los Santos, Laura Fincias Marin TECHNICIAN Joana Pal\u00e9s Huix, (2020 DI the administration of anaesthetics and analgesics (2020 DI 102). ogia de sistemes per a la diagnosi i personalitzat per a en la s\u00edndrome d'Alport (IA&biologia per d'Alport). La Fundaci\u00f3 La Marat\u00f3 de TV3. 2021-2024. PI: Montserrat Vallverd\u00fa.SELECTED PUBLICATIONS Barranco M, Sol\u00e0 P, Picart S, Kanaan S, F onollosa J, Belke D, Guo W, Zhong X, Sun serious games and gamification Ra\u00fcl Ben\u00edtez Iglesias, PhD Our group has been granted a national project for the study of heart fibrillation phenomena at the cellular and molecular levels, a project in which we will be applying pattern and deep learning tools Dr Tha\u00efs Agut's Neonatal Brain research group at Sant Joan de D\u00e9u Barcelona Children's Hospital, and as a result of our collaboration a final master's degree project has been carried out. We participated actively in the 3rd edition of the course \"Transversal Programme in Medical Image Postprocess. Training to Research\", financed by EIT Additionally, we published two articles in journals of acknowledged prestige in collaboration with the Neurogenetics and Molecular Medicine research group of the Sant Joan de D\u00e9u Barcelona Research Institute (IRSJD), coordinated by Dr Francesc Palau and Dr Janet Hoenicka. Lastly, a collaboration began with researchers of Amrita University (India) to develop new tools for interpretation of deep learning models. MEMBERS STAFF RESEARCHER Dolors Ayala Vallesp\u00ed, Maria G\u00f3mez, Merc\u00e8 Ginjaume Egido, Robert Joan Ariny\u00f3, N\u00faria Roma, Llu\u00eds Solano Albages, Daniela Tost Pardell, Marc Ariel von Barnekow SELECTED PROJECTS Analisis automatic o MINECO. 2018-2021. PI: Ra\u00fcl Ben\u00edtez An\u00e1lisis comput acional del impacto de riesgos gen\u00e9ticos y cl\u00ednicos en la se\u00f1alizaci\u00f3n molecular y disfunciones electrofisiol\u00f3gicas en fibrilaci\u00f3n auricular. (PID2020- 116927RB-C22). dosis ocupacional es en cristalino en instalaciones sanitarias y de investigaci\u00f3n (EDOCI). Propuestas de vigilancia radiol\u00f3gica individual. Consejo de Seguridad Nacional. 2019-2022. PI: Merc\u00e8 Ginjaume. SELECTED PUBLICATIONS Bonet Gomar C, HEALTH TECHNOLOGIES AND INNOVATION Cantarero L, Ju\u00e1rez E, Civera A, Rodriguez M, Roldan M, Ben\u00edt ez R (Q1). a A, Dominguez L, Mart\u00ednez P, Serrano C, Vallmitjana A, Ben\u00edtez R et al. Mitochondria M, Nater a D, CI, Altimir A, Osuna M et Translational Diagnostics: An In-House Pipeline to Validate Genetic Variants granted 3 European projects in 2021, as coordinators in one case, as well as one AEI (Spanish Research Agency) project. Likewise, our group has an ERC Starting Grant, two H2020 projects and four projects from the AEI. We published a total of 38 articles in JCR indexed journals and 2 book chapters, in addition to presenting 11 guest lectures and 20 papers in international conferences. Our doctoral students presented a total of five theses, one in the form of industrial doctorate. All five theses were graded Excellent Cum Laude. Likewise, Dr Cristina Canal obtained an ICREA Academia Prize for her research career, and Carles Mas-Moruno obtained the Marcial Moreno-Ma\u00f1as 2020 Prize, awarded by the Catalan Section of the Spanish Royal Society of Chemistry (RSEQ). Several European Society of Biomaterials (ESB) (Portugal, 06/09/2022); Llu\u00eds Oliver won the Audience Award in the competition \"Present Your Thesis in 4 Minutes\", of the Catalan Foundation for Research and Innovation (FCRI) (Barcelona, 22/06/2021); and Miguel Mateu obtained the the \"Best Thesis Presentation\" at the 3rd IRSJD Scientific Conference (Barcelona, 28/10/2021). Lastly, our group has two University- Business Chairs with Soadco/ Klockner and AMES Group, as well as a large number of agreements with companies of biohealth MEMBERS STAFF RESEARCHER Andrea Malandrino, Albert Espona Noguera, Jos\u00e9 Manuel Garc\u00eda Torres, Montserrat Espa\u00f1ol Pons, Francesc Xavier Gil Mur, Jordi Guillem Mart\u00ed, Jose Mar\u00eda Manero Planella, Carles Mas Moruno, Marta Pegueroles Neyra, Daniel Rodr\u00edguez Rius POSTDOC ASSOCIATED RESEARCHERS Irene PHD Victor Chausse Calbet, Claudia Konka, Joanna Magdalena, Llu\u00eds Oliver Cervell\u00f3, Yago Raymond Llorens, Elisa Rup\u00e9rez de Gracia TECHNICIAN Meritxell S\u00e1nchez Herv\u00e1s, Noelia Aparicio B\u00e1denas, Meritxell Molmeneu PI: Canal. Plasmas (COST applications (PID2020- 114019RB-I00). Agencia Estatal de Investigaci\u00f3n, Ministerio de Ciencia, Innovaci\u00f3n y Universidades. 2021- 2024. PI: Carles Mas-Moruno. SELECTED PUBLICATIONS Garc\u00eda C, C\u00f3rdoba LC, Buxadera J, Mar quina A, Jim\u00e9nez E, Ginebra MP et al. Zn-Mg and Zn-Cu alloys for 2021;6(12):4430-4446. (Q1). Oliver Martin H, Re yes L, Noureddine F, Ada Cavalcanti E, Ginebra MP et E, Liv ersain Pou J, Ginebra MP, Canal C. Evaluation of the effects of cold atmospheric Villanueva, PhD The BIOsignal Analysis for Rehabilitation and Therapy Research Group (BIOART) has been officially recognised by the Government of Catalonia since 2008. It is formed by four professors, three post-doctoral researchers, four cognitive rehabilitation, respiratory 87 INSTITUT DE RECERCA TRANSVERSAL PROGRAM HEALTH TECHNOLOGIES AND INNOVATION system, and internal medicine. The group belongs to the Biomedical Engineering Research Centre (CREB, from the Catalan) of the Polytechnic University of Catalonia (UPC). Between 2020 and 2022, our group has received financing from various competitive projects that has allowed us to strengthen our three research lines on motor, cognitive and respiratory system rehabilitation, and to launch a new line of research on artificial intelligence for the support of decision-making in the diagnosis, treatment and rehabilitation of high- impact disorders. Of special note are a concept test of the national R&D&I programme addressed to the challenges of society (Spanish Ministry of Science and Innovation), a TecnioSpring Industry project financed by the Marie Europe), and a Beatriu de Pin\u00f3s post-doctoral grant, all three of which were obtained in 2021. Our group also receives funding from other Llavor (Seed and Product) (AGAUR- Catalonia), CaixaImpulse (La Caixa Foundation), INNOTEC (ACCI\u00d3; Government of Catalonia), and the National Plan for Scientific and Technical Research and for Innovation (MINECO/MICINN). During the past year, nine articles were published in JCR indexed journals (six in the first quartile) and was registered. Our group also received the Prize for the Best Innovation Patent for Its Application to the Market, awarded by the UPC's Social Council. MEMBERS STAFF RESEARCHER Joan Francesc Alonso Lopez, PI: Miquel \u00c1ngel Ma\u00f1anas. MYO ARM: tecnolog\u00eda inteligente para la rehabilitaci\u00f3n motora (PDC2021-120818-I00). Agencia Estatal De Investigaci\u00f3n. 2021-2023. PI: Miquel \u00c1ngel Ma\u00f1anas. Tecnol og\u00edas innovadoras para monitorizar y personalizar la rehabilitaci\u00f3n interdisciplinar de pacientes de cuidado intensivo (PID2020-117751RB-I00). Agencia Estatal De Investigacion. 2021-2024. PI: Mohebian MR, Sami R, Haghjoo y S, Dehghan F et al. Automatic Classification Between COVID-19 and Non- Pneumonia (Q1). Migliorelli C, Romer o S, Bachiller A, Aparicio J, Alonso JF, Ma\u00f1anas MA et al. Improving C A, Hernandez AM, Serna LY, Ma\u00f1anas MA. An integrated mathematical model of the cardiovascular and respiratory response to exercise: model- building and (Q1). Tos t A, Migliorelli C, Bachiller A, Medina IF, Romero S, Garcia A et al. Choosing Strategies to Deal with Artifactual STAFF RESEARCHER Ramon Brag\u00f3s Badia, Mireya Fern\u00e1ndez Chimeno, Angel Garc\u00eda Gonzalez, Miguel J Garc\u00eda Hernandez, Lexa Nescolarde Selva, Juan Ramos Castro, Pere Joan Riu SELECTED PROJECTS Integrating PUBLICATIONS Hern\u00e1ndez JA, Nesc olarde L, Roca E, Revuelta E, Ara J, Bayes A. Marathon Running Increases Synthesis and Decreases Mateu M, Guede F, Rodriguez N, Garc\u00eda MA, Ramos J, Fern\u00e1ndez C. A non-contact camera-based method Amor\u00f3s X, Gely C, Nieto JC et al. Phase angle by electrical bioimpedance is a predictive factor of hospitalisation, falls and important step forward 88 INSTITUT DE RECERCA TRANSVERSAL PROGRAM HEALTH TECHNOLOGIES AND INNOVATION in the process of providing a has provided an advance in cognitive aspects which, with the knowledge of the steps of a specific surgical procedure and the capacity to perceive and to the evolution in real time, allows surgical performed by one or more assistant surgeons. In the field intraluminal conducted with the interface resulting from the studies. We have studied the effect on the improvement achieved as a result of both the type of device used (endoscope) and the form of presentation of the information to the intervening professionals, as well as the effect of either provision autonomy to the exploratory robotic device. Work was carried out on a colon simulator, which has been developed to allow progress in this line, and results of specialists are now available. 2021 began specifically of mobility for the user's action as well as operativity in his or her surroundings. The project comprises two different parts. On the one the of the chair-exoskeleton itself, providing mobility, posture, and assistance for the action of the user's arms. This entails the challenge of making the human anatomy compatible with an external structure. And on the other hand, the project involves the design of an intelligent interface that will allow users with motor limitations to control their movement from one place to another, their posture, and their arm actions in an intuitive way that is adapted to their physical constraints. Likewise, negotiations have been resumed to reach an understanding on our cooperation with the Norwegian company Topro, after the postponement of the new agreement on this second phase of the process due to the pandemic. Now that the feasibility has been demonstrated of our systems for user monitoring support and walker control, which have already been produced and assessed, this agreement will allow to robotisation of Topro's walkers. We have also begun to work on the creation of the company that is to implement this project, on the development of its business plan, and on the process of its founding. MEMBERS STAFF RESEARCHER Joan Aranda L\u00f3pez, Josep Fern\u00e1ndez Ruzafa, Manel Frigola Bourlon, Enric Xavier Mart\u00edn Rull, Antonio Benito Mart\u00ednez Velasco r de Econom\u00eda, PUBLICATIONS Finocchiaro M, Cortegoso P, Hernansanz A, Marino N, Amr am D, Casals A et al. Training Simulators for Gastrointestinal Endoscopy: project of the telethon programme La Marat\u00f3 de TV3, in collaboration with Sant Joan de D\u00e9u Barcelona Children's Hospital, and we were also granted a TECNIOSpring Industry (Horizon Europe) programme. Likewise, during this period, our group led projects in progress financed by Spanish Research Agency (AEI) (Research Challenges), AGAUR (Product), and the European Institute of Innovation and Technology (EIT Health). Six articles were published in JCR indexed journals in this period, 10 papers were presented in scientific conferences, and a doctoral thesis co-directed by a researcher of our group was presented at Rice University (United States). Additionally, our group coordinated the National Network of Excellence in Biomechanics Research, financed by Spanish Research Agency (AEI) and formed by 10 Spanish groups in the biomechanics field. We are also an active member of the innovation networks Xartec Salut i4KIDS, led by CREB (Research Centre for Biomedical Engineering) and Sant Joan de D\u00e9u Barcelona Children's Hospital, respectively. Lastly, Dr Josep Maria Font has chaired the Technical Committee for Multibody Dynamics of the International Federation for the Promotion of Mechanism and Machine Science (IFToMM). In 2021, our research group received the Polytechnic University of Catalonia (UPC) Prize for Social Commitment in the Field of Inclusion, and a mention in the UPC Prize for Valorisation of Research, both of which are granted by the UPC's Social Council. MEMBERS STAFF RESEARCHER Oriol Al\u00eds Gonz\u00e1lez, POSTDOC Massimo Cenciarini, Albert Peiret 89 INSTITUT DE RECERCA TRANSVERSAL PROGRAM HEALTH TECHNOLOGIES AND INNOVATION Gim\u00e9nez, Joan Lobo Prat PHD STUDENTS Jes\u00fas de Miguel Fern\u00e1ndez, Michael Ray Epke, Antonio Rodr\u00edguez Fern\u00e1ndez, M\u00edriam Febrer Nafr\u00eda SELECTED PROJECTS ArmTracker: Un sistema portable per la funci\u00f3 motora de les extremitats superiors durant la vida di\u00e0ria per a pacients muscular de Duchenne i atr\u00f2fia muscular espinal (202023-32). La Fundaci\u00f3 La Marat\u00f3 de et rob\u00f2tic que permet tornar a caminar de Josep detection in Research Area carried out its research activity in the framework of competitive projects with public financing as well as in projects conducted with our own funds, which have a direct impact on our institution. Notable among these activities was the development of the Patient Participation Plan, which will be implementing its first strategic plan in the period 2022-2024. This plan will allow the preparation and orientation of a model centred on patients' needs. To this end, it will be essential to have patients' close involvement from the earliest phases of research to the final moment when the results of the projects are fed back to patients and disseminated. Another initiative of note is the start of the Science Agora project, which has the primary goal of making initiatives care the importance of involving society in these initiatives and to present the results of the projects in clearly understandable language. The scientific output of the Patient Participation Area was focused in 2021 on disseminating the results of projects financed by the European Commission in the field of collaborative research with patients and their families in relation the study paediatric the oral formulation of medicines (EPTRI Project), the analysis of the impact of the quarantine on Spanish families (Kids Corona Project), the conceptualisation paediatric (Conect4children participating de SELECTED PROJECTS \u00c1gora de la Ciencia. (FCT-20-16045). F undaci\u00f3n Espa\u00f1ola para la Ciencia y la IP: Bego\u00f1a Nafria Escalera. YEAH: to rare diseases, using collective intelligence for the generation of awareness and advanced knowledge on this large group of diseases. Commision. 2018-2021. IP: S, Jon A, Baro B, Balanza N, V aro R, Millat P et al. How Did the COVID-19 Lockdown Affect Children and Adolescent's Well- Being: Oral C, Somers F, Jose Vicente Edo M, Prieto L et al. Understanding multi-stakeholder needs, preferences and IF:3,377. TRANSVERSAL PROGRAM HEALTH TECHNOLOGIES AND INNOVATION Innovation in health technologies Jaume P\u00e9rez Payarols, MD, group's activity which is formed by 26 institutions of excellence. They are all focused the success achieved in terms of participation in the first edition of the Pediatric Innovation Day (PID). In order to comply with the new legislation, HSJD's 3D authority of the Autonomous Region, which in our case is the Government of Catalonia (General Directorate for Health Planning and Regulation). This licence is valid for 5 years. This year Sant Joan de D\u00e9u Barcelona Children's Hospital received the prize for the Best Innovating Hospital at the BHHSummit 2021 held by Lastly, mention should also be made of our new spin-off Ephion Health S.l., a pioneer in the use of artificial intelligence to monitor the evolution of patients with disorders affecting their mobility, in cooperation with Eurecat Technology Centre and the Collider, the Mobile World Capital Barcelona (MWCapital) innovation programme. MEMBERS STAFF RESEARCHER Marta Ayats Soler, Carmen De la Gala Otero, Jos\u00e9 M. Quintill\u00e1 Mart\u00ednez, Josep Rubio Palau, Arian Tarbal Roquer, Arnau Valls Esteve ASSISTANT RESEARCHER Merc\u00e8 i adopci\u00f3 de la Fabricaci\u00f3 Additiva / Impressi\u00f3 3D a la ind\u00fastria de Salut (QuirofAM). (COMRDI16-1-0011-06). Departament de Salut - Generalitat de Catalunya. 2018-2021. IP: Arnau Valls Esteve. AC ADOM_Assegurant la continu\u00eftat assistencial domicili\u00e0ria. (COMRDI15-1-0026). Departament de Salut - Generalitat de Catalunya. 2016-2021. IP: Arnau Valls Esteve. Perfil t \u00e9cnico en las Unidades 3D sanitarias. El binomio Imagen para el Diagn\u00f3stico y Fabricaci\u00f3n Mec\u00e1nica, hibridaci\u00f3n de futuro en FP. (AFP21/00052). Ministerio de educaci\u00f3n. 2021-2023. IP: Arnau Valls Esteve. Families4Health (F4H), un pr oyecto para la formaci\u00f3n en h\u00e1bitos saludables para familias desfavorecidas. Fundaci\u00f3n Ramon Prado i Pint\u00f3. 2020-2022. IP:Arian Tarbal Roquer. Boc calatte LA, Gemelli NA, Smith DE et al. Machine learning risk prediction of mortality J. Amblyopia due a dentigerous cyst. Case report and literature review. J FR OPHTALMOL. 2021;44(8):1249-1255. IF:0,818. (Q4). Vanesa V, Ir ene MP, Ayats M, Parri Ferrandis F, Miguel S, Mireia RM et al. Accuracy of virtually planned mandibular Casteele E, Nadjmi N, De Praeter M, Dunaway D. Virtual planning in Le Fort III distraction osteogenesis: A Rosa, 39-57 08950 Esplugues de "}